[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 2220
1. Pramateftakis MG: Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy. Tech Coloproctol; 2010 Nov;14 Suppl 1:S49-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimizing colonic cancer surgery: high ligation and complete mesocolic excision during right hemicolectomy.
  • The principles of CME and high ligation have been applied by us during colonic resections for cancer.
  • One patient developed a metachronous rectal carcinoma 28 months after his surgery, for which he underwent an abdoperineal resection.
  • It is important to remember that colon cancer treatment today is multimodal and that the improvement in patients' survival in the last decades is surely linked with the improvement in chemotherapy and the advances in the agents used.
  • However, optimal surgery is with no doubt an important element of good oncological outcome, as the experience with rectal cancer treatment has taught us.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Oncol. 2009;48(8):1152-6 [19863223.001]
  • [Cites] Am J Surg. 2007 Sep;194(3):349-54 [17693281.001]
  • [Cites] Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5 [19016817.001]
  • [Cites] J R Soc Med. 1988 Sep;81(9):503-8 [3184105.001]
  • [Cites] Ann Surg. 2006 Oct;244(4):602-10 [16998369.001]
  • (PMID = 20697925.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


2. Schowinsky JT, Epstein JI: Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer. Am J Surg Pathol; 2006 Jul;30(7):866-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
  • Rectal tissue is often seen in needle biopsies of the prostate gland.
  • On rare occasion distorted rectal glands can mimic prostatic adenocarcinoma, an issue not previously addressed in the peer-reviewed literature.
  • We evaluated 16 prostate needle biopsies received in consultation where the submitting pathologist questioned whether a focus of rectal tissue was prostate cancer.
  • In addition to the distorted architecture, features mimicking prostate cancer included:.
  • (1) blue-tinged intraluminal mucinous secretions in 10 cases (63%), (2) prominent nucleoli in 6 cases (37%), (3) mitotic activity in 6 cases (37%), (4) extracellular mucin in 5 cases (31%), and (5) adenomatous changes of the rectal tissue in 1 case (6%).
  • Immunohistochemical results further mimicked prostate cancer with negative stains for the basal cell markers high-molecular weight cytokeratin (n=6) and p63 (n=4), and positive stains for racemase in 4 of 5 biopsies.
  • Diagnostic clues to recognizing that these foci were distorted rectal fragments were the presence of (1) lamina propria in 12 cases (75%), (2) rectal tissue located on a detached fragment of tissue in 10 biopsies (63%), (3) associated inflammation in 10 cases (63%), (4) goblet cells in 7 cases (44%), and (5) muscularis propria in 6 cases (37%).
  • Rectal glands are associated with many of the classical features of prostate cancer, and immunohistochemistry may be misleading.
  • Recognition of these features mimicking prostate cancer and awareness of other findings that are diagnostic of rectal tissue on biopsy can prevent a misdiagnosis of atypical prostate glands or prostate cancer.
  • [MeSH-major] Adenocarcinoma / pathology. Biopsy, Needle. Diagnostic Errors. Prostatic Neoplasms / pathology. Rectum / anatomy & histology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Intestinal Mucosa / anatomy & histology. Intestinal Mucosa / metabolism. Keratins / metabolism. Male. Mucins / metabolism. Prostate-Specific Antigen / metabolism. Racemases and Epimerases / metabolism


3. Yan BM, Van Dam J: Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer. Can J Gastroenterol; 2008 Apr;22(4):405-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer.
  • Pancreatic cancer is the second most frequent gastrointestinal malignancy and carries a dismal prognosis.
  • Endoscopic ultrasound (EUS) is an established technique for the diagnosis and staging of pancreatic adenocarcinoma.
  • Interventional EUS via fine needle injection (FNI) for the treatment of pancreatic cancer is a rapidly expanding field.
  • The present article reviews the up-to-date developments in EUS FNI for intratumoural pancreatic cancer therapy, including antitumoural agents, immunotherapy, ablative techniques and new delivery systems.
  • EUS FNI may be an exciting new technique for the delivery of desperately needed novel therapies for pancreatic cancer.

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Intern Med. 2004 Nov 16;141(10):753-63 [15545675.001]
  • [Cites] Gastrointest Endosc. 1999 Sep;50(3):392-401 [10462663.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):320-3 [16168826.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):285-98 [16549328.001]
  • [Cites] Endoscopy. 2006 Apr;38(4):399-403 [16680642.001]
  • [Cites] Cochrane Database Syst Rev. 2006;(3):CD002093 [16855985.001]
  • [Cites] Gastrointest Endosc. 2006 Sep;64(3):412-7 [16923491.001]
  • [Cites] JAMA. 2007 Jan 17;297(3):267-77 [17227978.001]
  • [Cites] Gastrointest Endosc. 2007 Mar;65(3):448-53 [17173909.001]
  • [Cites] J Clin Oncol. 2007 May 20;25(15):1960-6 [17452677.001]
  • [Cites] Endoscopy. 2007 Jun;39(6):530-4 [17554649.001]
  • [Cites] Endoscopy. 2008 Apr;40(4):314-20 [18283622.001]
  • [Cites] Gastrointest Endosc. 1999 Dec;50(6):786-91 [10570337.001]
  • [Cites] Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4 [10615932.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1325-35 [10717613.001]
  • [Cites] Cancer Control. 2000 Sep-Oct;7(5):428-36 [11000612.001]
  • [Cites] Cancer Control. 2000 Sep-Oct;7(5):437-51 [11000613.001]
  • [Cites] Cancer Res. 2001 Sep 1;61(17):6445-50 [11522639.001]
  • [Cites] CA Cancer J Clin. 2001 Jan-Feb;51(1):15-36 [11577478.001]
  • [Cites] Surgery. 2002 Feb;131(2):135-8 [11854690.001]
  • [Cites] Gut. 2002 Apr;50(4):549-57 [11889078.001]
  • [Cites] Semin Cancer Biol. 2002 Feb;12(1):33-42 [11926410.001]
  • [Cites] Gastrointest Endosc. 2002 Oct;56(4 Suppl):S6-S12 [12297741.001]
  • [Cites] Clin Cancer Res. 2003 Feb;9(2):555-61 [12576418.001]
  • [Cites] Ann N Y Acad Sci. 2003 Apr;987:180-7 [12727638.001]
  • [Cites] Dis Colon Rectum. 2004 Jan;47(1):59-65 [14719152.001]
  • [Cites] Gastrointest Endosc. 2004 Jan;59(1):95-9 [14722560.001]
  • [Cites] J Clin Oncol. 2004 Feb 15;22(4):592-601 [14726502.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1017-21 [15001240.001]
  • [Cites] Curr Gastroenterol Rep. 2004 Apr;6(2):104-10 [15191687.001]
  • [Cites] Curr Gastroenterol Rep. 2004 Apr;6(2):119-25 [15191689.001]
  • [Cites] Cancer. 1987 Jun 15;59(12):2006-10 [3567862.001]
  • [Cites] Endoscopy. 1993 Feb;25(2):143-50 [8491130.001]
  • [Cites] Radiology. 1994 Mar;190(3):745-51 [8115622.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2403-13 [9196156.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):317-23 [9440759.001]
  • [Cites] Gastrointest Endosc Clin N Am. 2005 Jan;15(1):169-77, x [15555959.001]
  • (PMID = 18414717.001).
  • [ISSN] 0835-7900
  • [Journal-full-title] Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • [ISO-abbreviation] Can. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Immunologic Factors; 0 / ONYX015; 0 / Viral Vaccines
  • [Number-of-references] 46
  • [Other-IDs] NLM/ PMC2662900
  •  go-up   go-down


Advertisement
4. Ishigami S, Kato K, Baba K, Onohara S, Hatanaka S, Aridome K, Okumura H, Matsumoto M, Natsugoe S, Aikou T: [A case of advanced rectal carcinoma, preoperative chemo-radiation therapy leading to histological complete response]. Gan To Kagaku Ryoho; 2006 Sep;33(9):1345-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced rectal carcinoma, preoperative chemo-radiation therapy leading to histological complete response].
  • Perforative rectal cancer was diagnosed, and an emergency laparotomy was done.
  • Preoperatively rectal cancer was assessed to invade the sacral bone and prostate.
  • Once complete regression of the rectal cancer by chemo-radiation therapy has been achieved, relapse of the tumor was reported to be rare.
  • Preoperative chemo-radiation therapy is an effective tool to control the advanced rectal cancer.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Pelvic Exenteration. Preoperative Care. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy. Rectum / surgery

  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16969039.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil; CF regimen
  •  go-up   go-down


5. Sadahiro S, Suzuki T, Maeda Y, Tanaka Y, Nakamura T, Saguchi T, Yasuda S, Makuuchi H, Murayama C, Ohizumi Y: Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma. Hepatogastroenterology; 2007 Jun;54(76):1107-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma.
  • This study attempts to evaluate retrospectively the significance of apoptosis-related and proliferative indexes in biopsy specimens obtained before treatment as predictors of sensitivity to RT or to CRT for locally advanced rectal adenocarcinoma.
  • METHODOLOGY: The subjects were 96 patients with clinical T3-4/Nx/M0 adenocarcinoma of the middle third or lower third of the rectum.
  • RESULTS: AI-positivity, p53-negativity, p21-positivity and well differentiated adenocarcinoma were predictors of high sensitivity in RT group, whereas AI-positivity alone was the predictor in CRT group.
  • The addition of UFT to RT increased sensitivity in patients with p53-positivity, p21-negativity and moderately differentiated adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Biomarkers, Tumor / analysis. Drug Resistance, Neoplasm. Radiation Tolerance. Rectal Neoplasms / therapy

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17629049.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; 1-UFT protocol
  •  go-up   go-down


6. Wang H, Wei XZ, Fu CG, Zhao RH, Cao FA: Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol; 2010 Nov 14;16(42):5375-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Patterns of lymph node metastasis are different in colon and rectal carcinomas.
  • AIM: To describe patterns of lymph node metastasis in invasive colon and rectal carcinomas.
  • METHODS: Clinical data of 2340 patients with colorectal carcinoma (stage I to III) who received radical resection, was retrospectively reviewed.
  • Of the 2340 patients, 1314 patients suffered from rectal carcinoma and 1026 from colon carcinoma.
  • Patients with rectal cancer who received neoadjuvant chemoradiation therapy were excluded.
  • RESULTS: Lymph node retrieval in the rectal carcinoma group was significantly lower than that in the colon carcinoma group (P < 0.001), while positive lymph node retrieval in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001).
  • The proportion of lymph node positive (N+) cases was higher (patients with one or more positive lymph nodes) in the rectal carcinoma group (P = 0.004).
  • In addition, the lymph node ratio (the ratio of number of positive lymph nodes over the number of lymph nodes examined) of stage III cases in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001).
  • CONCLUSION: Rectal carcinomas seem more prone to metastasize to the lymph nodes than colon carcinomas, which may be of potential clinical significance.
  • [MeSH-major] Colonic Neoplasms / pathology. Lymphatic Metastasis / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Aged. Female. Humans. Lymph Node Excision. Lymph Nodes / pathology. Male. Middle Aged. Neoplasm Staging. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 2002 Oct;236(4):416-21; discussion 421 [12368669.001]
  • [Cites] Dis Colon Rectum. 2002 Feb;45(2):200-6 [11852333.001]
  • [Cites] Cancer. 1998 Aug 15;83(4):666-72 [9708929.001]
  • [Cites] Arch Surg. 1998 Aug;133(8):894-9 [9711965.001]
  • [Cites] J Gastrointest Surg. 2004 Dec;8(8):1032-9; discussion 1039-40 [15585391.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Dec;4(12):1522-7 [16979956.001]
  • [Cites] J Gastrointest Surg. 2007 May;11(5):660-5 [17468927.001]
  • [Cites] World J Surg. 2007 Jul;31(7):1485-90 [17510767.001]
  • [Cites] Ann Surg Oncol. 2007 Aug;14(8):2257-62 [17520316.001]
  • [Cites] World J Gastroenterol. 2008 Aug 21;14(31):4903-8 [18756598.001]
  • [Cites] Ann Surg Oncol. 2008 Oct;15(10):2668-76 [18618181.001]
  • [Cites] Dis Colon Rectum. 2009 Apr;52(4):549-57 [19404052.001]
  • [Cites] Ann Surg. 2008 Dec;248(6):968-78 [19092341.001]
  • [Cites] Br J Cancer. 2009 May 19;100(10):1530-3 [19401684.001]
  • [Cites] Dis Colon Rectum. 2009 Jul;52(7):1244-50 [19571700.001]
  • [Cites] Dis Colon Rectum. 2009 Dec;52(12):1941-8 [19934913.001]
  • [Cites] BMC Cancer. 2010;10:267 [20529352.001]
  • [Cites] BMC Gastroenterol. 2010;10:61 [20550703.001]
  • [Cites] J Clin Oncol. 2004 May 15;22(10):1785-96 [15067027.001]
  • [Cites] J Natl Cancer Inst. 2001 Apr 18;93(8):583-96 [11309435.001]
  • [CommentIn] World J Gastroenterol. 2011 Aug 7;17(29):3465-6 [21876640.001]
  • (PMID = 21072903.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2980689
  •  go-up   go-down


7. Liszka Ł, Zielińska-Pajak E, Pajak J, Gołka D, Huszno J: Coexistence of gastrointestinal stromal tumors with other neoplasms. J Gastroenterol; 2007 Aug;42(8):641-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common accompanying neoplasms were colorectal (nine cases) and gastric (four cases) adenocarcinoma, as well as pancreatic adenocarcinoma (three cases).
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Pancreatic Ductal / pathology. Colorectal Neoplasms / pathology. Gastrointestinal Stromal Tumors / pathology. Neoplasms, Multiple Primary / pathology. Pancreatic Neoplasms / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Biopsy. Confidence Intervals. Diagnosis, Differential. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Poland / epidemiology. Retrospective Studies


8. Sasaki M, Kobayashi T, Ono K, Sugano O, Sasao S, Hoshi S: [Small cell carcinoma of the prostate: a case report]. Hinyokika Kiyo; 2006 Sep;52(9):719-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Small cell carcinoma of the prostate: a case report].
  • Digital rectal examination showed an enlarged, irregular prostate with stony hardness.
  • We performed a prostate biopsy and histological examinations indicated poorly differentiated adenocarcinoma with a Gleason score of 5+5=10.
  • A computed tomographic (CT) scan revealed a prostatic tumor invading the bladder, seminal vesicle and rectum.
  • He was diagnosed with a stage T4N1M0 adenocarcinoma of the prostate.
  • Histological and immunohistological examinations were repeated; suggesting small cell neuroendocrine carcinoma of the prostate.
  • [MeSH-major] Carcinoma, Small Cell / pathology. Prostate / pathology. Prostatic Neoplasms / pathology
  • [MeSH-minor] Aged. Biomarkers, Tumor / blood. Biopsy. Digital Rectal Examination. Humans. Male. Prostate-Specific Antigen / blood. Radiography, Abdominal. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17040059.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


9. Sakamoto S, Fu K, Kobayashi O, Matsuyama S, Miyazaki A, Ogura K, Watanabe S: Spontaneous complete regression of a rectal cancer. Endoscopy; 2009 Oct;41(10):910-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous complete regression of a rectal cancer.
  • We report a unique case of a biopsy-proven rectal cancer exhibiting spontaneous complete regression in an extremely short period of 3 months.
  • Colonoscopy showed a sessile polyp, about 25 mm in diameter, in the middle part of the rectum.
  • Instead of endoscopic resection, two endoscopic biopsies were taken for histological evaluation, as an invasive cancer was endoscopically suspected.Well-differentiated invasive adenocarcinoma was revealed, and thus surgical resection was planned.
  • [MeSH-major] Adenocarcinoma / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Aged, 80 and over. Colonoscopy. Humans. Male. Neoplasm Invasiveness

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19685424.001).
  • [ISSN] 1438-8812
  • [Journal-full-title] Endoscopy
  • [ISO-abbreviation] Endoscopy
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


11. Morello E, Martano M, Squassino C, Iussich S, Caccamo R, Sammartano F, Zabarino S, Bellino C, Pisani G, Buracco P: Transanal pull-through rectal amputation for treatment of colorectal carcinoma in 11 dogs. Vet Surg; 2008 Jul;37(5):420-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transanal pull-through rectal amputation for treatment of colorectal carcinoma in 11 dogs.
  • OBJECTIVE: To evaluate outcome after transanal rectal pull-through amputation of single colorectal adenocarcinoma and in situ carcinoma (Tis) in dogs.
  • ANIMALS: Dogs (n=11) with colorectal cancer.
  • RESULTS: Adenocarcinoma (8) and Tis (2) were removed with 3-6 cm of grossly normal tissue, cranial and caudal to the tumor, or in 1 Tis with 2 cm grossly normal tissue, cranial and caudal.
  • In the other dogs, postoperative complications included short-term tenesmus (6 dogs), rectal bleeding (11), rectal stricture (3), and long-term fecal incontinence (1).
  • Postoperative recurrence and metastatic rates for adenocarcinoma were 18.2% and 0%, respectively.
  • CONCLUSION: En bloc excision of colorectal Tis and adenocarcinoma may be followed by a long survival.
  • CLINICAL RELEVANCE: Transanal rectal pull-through amputation is suitable for en bloc resection of colorectal neoplasia.
  • A combined abdominal-transanal approach should be reserved for tumors extending from the mid-cranial region of the rectum to the descending colon.
  • [MeSH-major] Adenocarcinoma / veterinary. Anal Canal / surgery. Colorectal Neoplasms / veterinary. Dog Diseases / surgery
  • [MeSH-minor] Animals. Disease-Free Survival. Dogs. Fecal Incontinence / epidemiology. Fecal Incontinence / veterinary. Female. Male. Neoplasm Recurrence, Local / veterinary. Postoperative Complications / epidemiology. Postoperative Complications / veterinary. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18986308.001).
  • [ISSN] 1532-950X
  • [Journal-full-title] Veterinary surgery : VS
  • [ISO-abbreviation] Vet Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Damin DC, Tolfo GC, Rosito MA, Spiro BL, Kliemann LM: Sentinel lymph node in patients with rectal cancer invading the anal canal. Tech Coloproctol; 2010 Jun;14(2):133-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel lymph node in patients with rectal cancer invading the anal canal.
  • BACKGROUND: To assess the feasibility of the sentinel lymph node procedure in patients with rectal cancer extending to the anal canal.
  • METHODS: Between January 2005 and April 2008, 15 patients with adenocarcinoma of the rectum with direct invasion of the anal canal and no clinical evidence of inguinal involvement were prospectively enrolled in the study.
  • Four patients (26.7%) had sentinel nodes identified as positive for metastatic adenocarcinoma.
  • CONCLUSIONS: The standardized procedure was highly effective in sampling inguinal sentinel nodes in very low rectal cancers, allowing the detection of subclinical metastatic disease.
  • Although this technique can be potentially useful for a subgroup of patients with isolated inguinal metastases, it cannot be routinely recommended for patients with rectal tumors invading the anal canal at this moment.
  • [MeSH-major] Adenocarcinoma / secondary. Anal Canal. Inguinal Canal. Rectal Neoplasms / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prospective Studies

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 2008 Aug;34(8):890-4 [18178364.001]
  • [Cites] Q J Nucl Med Mol Imaging. 2009 Feb;53(1):3-8 [18337684.001]
  • [Cites] Cancer Radiother. 2003 Nov;7 Suppl 1:85s-90s [15124549.001]
  • [Cites] Eur J Surg Oncol. 2006 Apr;32(3):247-52 [16289647.001]
  • [Cites] Gastroenterol Clin Biol. 2009 May;33(5):446-50 [19264433.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1984 Jun;10(6):811-9 [6429097.001]
  • [Cites] Cancer. 1993 Sep 15;72(6):2058-65 [8364884.001]
  • [Cites] Ann Surg Oncol. 2004 Mar;11(3 Suppl):259S-62S [15023764.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1027-9; discussion 1030-1 [12907894.001]
  • [Cites] Strahlenther Onkol. 2009 Apr;185(4):254-9 [19370429.001]
  • [Cites] Colorectal Dis. 2010 Apr;12(4):312-5 [19250258.001]
  • [Cites] Colorectal Dis. 2010 Oct;12(10 Online):e200-5 [19912287.001]
  • [Cites] Dis Colon Rectum. 1999 Nov;42(11):1464-6 [10566535.001]
  • [Cites] Am J Surg. 1994 Sep;168(3):285-7 [8080070.001]
  • [Cites] Surg Gynecol Obstet. 1989 Sep;169(3):238-42 [2672386.001]
  • [Cites] World J Urol. 2009 Apr;27(2):197-203 [18594830.001]
  • [Cites] Scand J Surg. 2002;91(4):336-8 [12558082.001]
  • [Cites] Radiother Oncol. 2001 Oct;61(1):15-22 [11578724.001]
  • [Cites] Br J Clin Pract. 1984 Sep;38(9):324-5 [6477814.001]
  • [Cites] J Surg Oncol. 1999 Mar;70(3):177-80 [10102348.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):741-7 [11597817.001]
  • [Cites] Dis Colon Rectum. 1990 Mar;33(3):212-6 [2311465.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1032-7 [12907896.001]
  • (PMID = 20424879.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


13. Vermaas M, Gosselink MP, Ferenschild FT, van den Aardweg E, Lont HE, Kemperman HW, van der Harst E, Tetteroo GW, Oostenbroek RJ, Dijkhuis CM, Eggermont AM, de Wilt JH: Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Eur J Surg Oncol; 2007 Sep;33(7):862-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
  • INTRODUCTION: After publication of the results of the Dutch TME-trial preoperative radiotherapy followed by TME-surgery was introduced in July 2001 in the region of the comprehensive cancer centre Rotterdam as standard treatment for rectal cancer.
  • The aim of this study is to identify the compliance to a new standardized treatment protocol i.e. the introduction of preoperative radiotherapy and to analyze the results of rectal cancer treatment in the Cancer Centre Rotterdam Region.
  • PATIENTS AND METHODS: A total of 521 patients with adenocarcinoma of the rectum were included in the period from 2001 to 2003.
  • RESULTS: There was a significant increase of preoperative radiotherapy for patients with a tumour in the lower two-third of the rectum (21% versus 69%, p<0.001).
  • CONCLUSION: The regional quality of rectal cancer surgery is conform preset quality-demands.
  • Pathology reports improved during registration, which illustrates the importance of registration to assess and improve quality of rectal cancer treatment.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Preoperative Care / methods. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17257804.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


14. Pasetto LM: Preoperative versus postoperative treatment for locally advanced rectal carcinoma. Future Oncol; 2005 Apr;1(2):209-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative versus postoperative treatment for locally advanced rectal carcinoma.
  • EPIDEMIOLOGY: Overall mortality of rectal cancer at 5 years is approximately 40%.
  • This cancer is commonly diagnosed at an early stage, but because of local relapse and/or metastatic disease, only half of radically resected patients can be considered disease free.
  • COMMON TREATMENT: The value of adding radiotherapy to surgery in the treatment of patients with resectable rectal cancer has been assessed in trials using either preoperative or postoperative irradiation.
  • IMPROVEMENTS IN TREATMENT: Preoperative radiotherapy and complete resection are established modalities for Stage II and III rectal cancer whilst data reporting improvement of survival by preoperative chemoradiotherapy are still not available.
  • [MeSH-major] Rectal Neoplasms / therapy
  • [MeSH-minor] Antineoplastic Agents. Clinical Trials as Topic. Combined Modality Therapy. Forecasting. Humans. Neoplasm Metastasis. Postoperative Care. Preoperative Care. Radiotherapy, Adjuvant

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16555993.001).
  • [ISSN] 1479-6694
  • [Journal-full-title] Future oncology (London, England)
  • [ISO-abbreviation] Future Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Number-of-references] 83
  •  go-up   go-down


15. Inai T, Sengoku A, Hirose E, Iida H, Shibata Y: Comparative characterization of mouse rectum CMT93-I and -II cells by expression of claudin isoforms and tight junction morphology and function. Histochem Cell Biol; 2008 Feb;129(2):223-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative characterization of mouse rectum CMT93-I and -II cells by expression of claudin isoforms and tight junction morphology and function.
  • In this study, we tried to characterize mouse cell lines by expression of claudin isoforms to use for studying epithelial TJs by overexpression or suppression of claudin(s) in the cells and found that claudin-2 was expressed in a few mouse rectum carcinoma cells, CMT93 cells.
  • [MeSH-major] Carcinoma / metabolism. Carcinoma / ultrastructure. Membrane Proteins / biosynthesis. Rectal Neoplasms / metabolism. Rectal Neoplasms / ultrastructure. Tight Junctions / metabolism. Tight Junctions / ultrastructure

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2006 Nov 24;281(47):36117-23 [17018523.001]
  • [Cites] Histochem Cell Biol. 2002 Jan;117(1):29-39 [11819095.001]
  • [Cites] Histochem Cell Biol. 2008 Feb;129(2):211-22 [17989991.001]
  • [Cites] J Biol Chem. 2005 Feb 4;280(5):3780-8 [15569684.001]
  • [Cites] J Cell Biol. 2001 Apr 16;153(2):263-72 [11309408.001]
  • [Cites] J Cell Biol. 1999 Oct 4;147(1):195-204 [10508866.001]
  • [Cites] Eur J Cell Biol. 1999 Dec;78(12):849-55 [10669103.001]
  • [Cites] Am J Physiol Cell Physiol. 2002 Jul;283(1):C142-7 [12055082.001]
  • [Cites] J Cell Biol. 1999 Nov 15;147(4):891-903 [10562289.001]
  • [Cites] Gut. 2007 Jan;56(1):61-72 [16822808.001]
  • [Cites] J Cell Sci. 2005 Jun 15;118(Pt 12):2683-93 [15928046.001]
  • [Cites] Am J Physiol Cell Physiol. 2004 Jun;286(6):C1213-28 [15151915.001]
  • [Cites] J Cell Biol. 2000 Apr 3;149(1):13-6 [10747082.001]
  • [Cites] Arch Histol Cytol. 2005 Dec;68(5):349-60 [16505581.001]
  • [Cites] J Cell Biol. 1998 Oct 19;143(2):391-401 [9786950.001]
  • [Cites] J Pathol. 1978 Jan;124(1):35-8 [722371.001]
  • [Cites] J Cell Biol. 1998 Jun 29;141(7):1539-50 [9647647.001]
  • [Cites] Am J Physiol Renal Physiol. 2003 Dec;285(6):F1078-84 [13129853.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3971-6 [12651952.001]
  • [Cites] J Cell Biol. 1988 Dec;107(6 Pt 1):2401-8 [3058723.001]
  • [Cites] J Cell Sci. 2000 Oct;113 Pt 19:3387-98 [10984430.001]
  • [Cites] Science. 1989 Aug 18;245(4919):718-25 [2672330.001]
  • [Cites] J Cell Sci. 1994 May;107 ( Pt 5):1347-57 [7929640.001]
  • [Cites] J Invest Dermatol. 2002 Jun;118(6):1073-9 [12060405.001]
  • [Cites] J Cell Biol. 1993 Dec;123(6 Pt 2):1631-3 [8276885.001]
  • [Cites] J Cell Biol. 2003 May 12;161(3):653-60 [12743111.001]
  • [Cites] Curr Opin Cell Biol. 2004 Apr;16(2):140-5 [15196556.001]
  • [Cites] J Cell Sci. 2002 Dec 15;115(Pt 24):4969-76 [12432083.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):511-6 [9892664.001]
  • [Cites] J Cell Physiol. 2005 Apr;203(1):15-26 [15389642.001]
  • [Cites] J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88 [8276896.001]
  • [Cites] Gastroenterology. 2001 Feb;120(2):411-22 [11159882.001]
  • [Cites] J Histochem Cytochem. 2006 Aug;54(8):933-44 [16651389.001]
  • [Cites] Lab Invest. 2003 Jul;83(7):1045-53 [12861044.001]
  • [Cites] J Cell Biol. 1996 Feb;132(3):451-63 [8636221.001]
  • [Cites] Gene Expr Patterns. 2006 Aug;6(6):581-8 [16458081.001]
  • [Cites] J Biol Chem. 2003 May 9;278(19):17350-9 [12615928.001]
  • (PMID = 18034259.001).
  • [ISSN] 0948-6143
  • [Journal-full-title] Histochemistry and cell biology
  • [ISO-abbreviation] Histochem. Cell Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Claudins; 0 / Cldn2 protein, mouse; 0 / Membrane Proteins; 0 / Protein Isoforms; 0 / RNA, Messenger
  •  go-up   go-down


16. Cancer and Leukemia Group B 89901, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ: Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol; 2006 Jun 1;24(16):2557-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
  • PURPOSE: The addition of oxaliplatin to fluorouracil in patients with advanced colorectal cancer improves survival.
  • This phase I/II study evaluated the addition of weekly oxaliplatin to preoperative continuous infusion fluorouracil (FU) and external-beam radiation therapy (RT) in patients with locally advanced rectal adenocarcinoma.
  • PATIENTS AND METHODS: Patients with clinical T3/T4 rectal adenocarcinoma and no evidence of metastases were treated with weekly oxaliplatin, continuous infusion FU 200 mg/m2 intravenously, and RT.
  • CONCLUSION: In this multicenter study, the addition of oxaliplatin to intravenous continuous infusion FU and RT for patients with locally advanced rectal cancer was associated with a high pathologic complete response rate but more toxicity than when FU is used alone.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Neoadjuvant Therapy / methods. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Clin Oncol. 2007 Feb 10;25(5):602-3; author reply 603 [17290071.001]
  • (PMID = 16636336.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA12046; United States / NCI NIH HHS / CA / CA12449; United States / NCI NIH HHS / CA / CA31946; United States / NCI NIH HHS / CA / CA32291; United States / NCI NIH HHS / CA / CA33601; United States / NCI NIH HHS / CA / CA47559
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


17. Liu C, Dong B, Lu A, Qu L, Xing X, Meng L, Wu J, Eric Shi Y, Shou C: Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer; 2010;10:359
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen.
  • BACKGROUND: Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues.
  • In this study, we investigated the prognostic potential of SNCG in colon cancer particularly in the patients with normal carcinoembryonic antigen (CEA) levels.
  • METHODS: SNCG levels were assessed immunohistochemically in cancer tissues from 229 colon adenocarcinoma patients with a mean follow-up of 44 months.
  • RESULTS: SNCG levels in colon adenocarcinoma were closely associated with intravascular embolus and tumor recurrence but independent of preoperative serum CEA levels.
  • CONCLUSIONS: Our results suggest for the first time that SNCG is a new independent predicator for poor prognosis in patients with colon adenocarcinoma, including those with normal CEA levels.
  • Combination of CEA with SNCG improves prognostic evaluation for patients with colon adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Carcinoembryonic Antigen / metabolism. Colonic Neoplasms / metabolism. Neoplasm Proteins / metabolism. Neoplasm Recurrence, Local / metabolism. gamma-Synuclein / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Colon / metabolism. Colon / pathology. Female. Humans. Immunoenzyme Techniques. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. Survival Rate. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 May 1;88(9):2154-63 [10813729.001]
  • [Cites] Cancer Lett. 2008 Sep 28;269(1):148-58 [18586385.001]
  • [Cites] J Clin Oncol. 2000 Oct 15;18(20):3586-8 [11032600.001]
  • [Cites] Clin Chem. 2001 Apr;47(4):624-30 [11274010.001]
  • [Cites] Cell Motil Cytoskeleton. 2001 Aug;49(4):218-28 [11746666.001]
  • [Cites] J Biol Chem. 2002 Sep 20;277(38):35050-60 [12121974.001]
  • [Cites] Eur J Cancer. 2003 Apr;39(6):718-27 [12651195.001]
  • [Cites] Acta Neuropathol. 2003 Aug;106(2):167-75 [12783249.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):920-5 [14504205.001]
  • [Cites] Oncogene. 2003 Oct 23;22(48):7593-9 [14576821.001]
  • [Cites] Cancer. 2004 Jul 1;101(1):58-65 [15221989.001]
  • [Cites] Dis Colon Rectum. 1993 Jul;36(7):636-43; discussion 643-4 [8348848.001]
  • [Cites] Cancer Res. 1997 Feb 15;57(4):759-64 [9044857.001]
  • [Cites] Science. 1997 Jun 27;276(5321):2045-7 [9197268.001]
  • [Cites] Nature. 1997 Aug 28;388(6645):839-40 [9278044.001]
  • [Cites] Trends Neurosci. 1998 Jun;21(6):249-54 [9641537.001]
  • [Cites] Hum Genet. 1998 Jul;103(1):106-12 [9737786.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):742-7 [9973226.001]
  • [Cites] J Surg Oncol. 1999 Jan;70(1):1-5 [9989413.001]
  • [Cites] Cancer Sci. 2004 Dec;95(12):955-61 [15596044.001]
  • [Cites] J Clin Oncol. 2005 May 20;23(15):3526-35 [15908663.001]
  • [Cites] Cancer Res. 2005 Sep 1;65(17):7635-43 [16140929.001]
  • [Cites] Breast Cancer Res Treat. 2005 Nov;94(1):25-35 [16142440.001]
  • [Cites] Int J Oncol. 2006 May;28(5):1081-8 [16596223.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):289-95 [16773211.001]
  • [Cites] Cell Motil Cytoskeleton. 2006 Aug;63(8):447-58 [16732559.001]
  • [Cites] Int J Oncol. 2006 Nov;29(5):1201-5 [17016652.001]
  • [Cites] Cancer Res. 2007 Jan 15;67(2):626-33 [17234772.001]
  • [Cites] Breast Cancer Res Treat. 2007 Mar;101(3):259-67 [16821081.001]
  • [Cites] Eur J Cancer. 2007 Jun;43(9):1348-60 [17512720.001]
  • [Cites] Int J Cancer. 2007 Sep 15;121(6):1296-305 [17534899.001]
  • [Cites] Ann Surg. 2007 Dec;246(6):1040-6 [18043108.001]
  • [Cites] Cancer. 2008 Feb 1;112(3):495-502 [18076013.001]
  • [Cites] Breast Cancer Res Treat. 2000 Jul;62(2):99-107 [11016747.001]
  • (PMID = 20604972.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen; 0 / Neoplasm Proteins; 0 / SNCG protein, human; 0 / gamma-Synuclein
  • [Other-IDs] NLM/ PMC2912867
  •  go-up   go-down


18. El-Bolkainy TN, Sakr MA, Nouh AA, El-Din NH: A comparative study of rectal and colonic carcinoma: demographic, pathologic and TNM staging analysis. J Egypt Natl Canc Inst; 2006 Sep;18(3):258-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparative study of rectal and colonic carcinoma: demographic, pathologic and TNM staging analysis.
  • OBJECTIVE: The aim is to determine the relative frequency of rectal carcinoma in a large recent surgical series.
  • In addition, rectal carcinoma is compared with colonic carcinoma with regard to demographic data, histological types and TNM stages.
  • Tumors of unfavorable histology included: Mucinous carcinoma, signet-ring carcinoma and undifferentiated carcinoma.
  • Rectal tumors contributed only 27% of cases, contrary to much higher previous reports from Egypt.
  • Patients with rectal carcinomas were younger, with more risk of suboptimal distal surgical margins.
  • CONCLUSIONS: Egyptian patients with rectal carcinoma are younger than those with colonic carcinoma.
  • Otherwise, patients with rectal carcinoma are similar to colonic carcinoma with regard to sex distribution, histological types and TNM stages.
  • [MeSH-major] Carcinoma / epidemiology. Carcinoma / pathology. Colonic Neoplasms / epidemiology. Colonic Neoplasms / pathology. Rectal Neoplasms / epidemiology. Rectal Neoplasms / pathology
  • [MeSH-minor] Adult. Age Factors. Aged. Demography. Egypt / epidemiology. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17671536.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


19. Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK: Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol; 2007 May;4(5):316-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.
  • BACKGROUND: Localized rectal cancer responds well to 5-fluorouracil and radiation-based regimens.
  • The case presented here is a complete pathological response seen in a patient with extensive and locally invasive carcinoma after receiving this combined treatment.
  • INVESTIGATIONS: Physical examination, rectal ultrasound, PET-CT scan, laboratory tests, proctoscopic examination, chest radiograph, rectal forcep biopsies with immunohistochemistry, and protein and flow cytometric analyses.
  • DIAGNOSIS: Large, invasive, ultrasound stage T4 carcinoma of the rectum, which was positive for survivin.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Cancer Cell. 2007 Jan;11(1):83-95 [17222792.001]
  • [Cites] Nat Clin Pract Oncol. 2006 Jan;3(1):24-40 [16407877.001]
  • [Cites] BMJ. 2006 Oct 14;333(7572):779 [16984925.001]
  • [Cites] J Clin Oncol. 2006 Nov 20;24(33):5313-27 [17060676.001]
  • [Cites] Dis Colon Rectum. 2000 Mar;43(3):338-45 [10733115.001]
  • [Cites] Nat Med. 2004 Feb;10(2):145-7 [14745444.001]
  • [Cites] Dis Colon Rectum. 1985 Jan;28(1):42-6 [3882360.001]
  • [Cites] Acta Radiol Diagn (Stockh). 1985 Jan-Feb;26(1):45-55 [3976421.001]
  • [Cites] Br J Surg. 1986 Jun;73(6):474-7 [3521785.001]
  • [Cites] AJR Am J Roentgenol. 1988 Feb;150(2):301-6 [3257314.001]
  • [Cites] Dis Colon Rectum. 1990 Aug;33(8):654-9 [2198147.001]
  • [Cites] Dis Colon Rectum. 1993 Feb;36(2):200-5 [8425429.001]
  • [Cites] Radiology. 1994 Mar;190(3):715-20 [8115617.001]
  • [Cites] J R Coll Surg Edinb. 1996 Aug;41(4):232-4 [8772070.001]
  • [Cites] Am J Surg. 1998 Apr;175(4):283-7 [9568652.001]
  • [Cites] Am Surg. 1999 Mar;65(3):205-8 [10075291.001]
  • [Cites] Cancer Res. 2005 Jun 1;65(11):4881-7 [15930309.001]
  • [Cites] J Clin Oncol. 2005 Nov 1;23(31):8136-9 [16258121.001]
  • [Cites] Nat Protoc. 2007;2(4):805-10 [17446880.001]
  • (PMID = 17464339.001).
  • [ISSN] 1743-4262
  • [Journal-full-title] Nature clinical practice. Oncology
  • [ISO-abbreviation] Nat Clin Pract Oncol
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01-CA98706; United States / NCI NIH HHS / CA / R21 CA099237; United States / NCI NIH HHS / CA / R21 CA099237-02; United States / NCI NIH HHS / CA / R01 CA098706; United States / NCI NIH HHS / CA / R01 CA098706-05; United States / NCI NIH HHS / CA / P01-CA80124; United States / NCI NIH HHS / CA / CA098706-05; United States / NCI NIH HHS / CA / P01 CA080124; United States / NCI NIH HHS / CA / P01 CA080124-07; United States / NCI NIH HHS / CA / R21- CA099237; United States / NCI NIH HHS / CA / CA099237-02; United States / NCI NIH HHS / CA / P01 CA080124-08
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 2S9ZZM9Q9V / Bevacizumab
  • [Other-IDs] NLM/ NIHMS109189; NLM/ PMC2686127
  •  go-up   go-down


20. Nakayama H, Takayama T, Hemmi A: Small necrotic liver metastasis with microscopic tumor embolism in hepatic vein: a case report and review of the literature. Int Surg; 2005 Nov-Dec;90(5):293-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Small liver metastasis of rectal carcinoma is mostly solid and rarely accompanied by necrosis.
  • A 53-year-old man, 2 years after rectal carcinoma resection, was noted to have a 15-mm liver tumor.
  • The resected tumor was metastatic liver cancer, the center of which had mostly atheromatous necrosis.
  • Liver tumors that grow should be suspected of being malignant and be resected.
  • [MeSH-major] Adenocarcinoma / pathology. Hepatic Veins. Liver Neoplasms / secondary. Neoplastic Cells, Circulating / pathology. Rectal Neoplasms / pathology

  • Genetic Alliance. consumer health - Embolism.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16625950.001).
  • [ISSN] 0020-8868
  • [Journal-full-title] International surgery
  • [ISO-abbreviation] Int Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 10
  •  go-up   go-down


21. Takayama O, Yamamoto H, Damdinsuren B, Sugita Y, Ngan CY, Xu X, Tsujino T, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M: Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. Br J Cancer; 2006 Oct 9;95(7):889-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology.
  • Whether peroxisome proliferator-activated receptor (PPAR) delta is a good target for the chemoprevention and/or treatment of colorectal cancer (CRC) remains controversial.
  • In cancer tissues, the PPARdelta protein was accumulated only in those cancer cells with highly malignant morphology, as represented by a large-sized nucleus, round-shaped nucleus, and presence of clear nucleoli.
  • Interestingly, the cancer tissue often contained both PPARdelta-positive and -negative areas, each retaining their respective specific morphological features.
  • Moreover, this pattern persisted even when PPARdelta-positive and -negative cells were aligned next to each other within a single cancer nest or gland and was present in the majority of CRC cases.
  • Peroxisome proliferator-activated receptor delta may have a supporting role in tumorigenesis, and the close association between PPARdelta expression and malignant morphology of CRC cells suggests a pivotal role in cancer tissue.
  • [MeSH-major] Adenocarcinoma / enzymology. Cell Transformation, Neoplastic / pathology. Colorectal Neoplasms / enzymology. PPAR delta / biosynthesis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Recent Prog Horm Res. 1999;54:345-67; discussion 367-8 [10548883.001]
  • [Cites] Cell. 1999 Oct 29;99(3):335-45 [10555149.001]
  • [Cites] Cancer. 1999 Nov 15;86(10):1944-51 [10570417.001]
  • [Cites] J Med Chem. 2000 Feb 24;43(4):527-50 [10691680.001]
  • [Cites] Clin Cancer Res. 2000 Apr;6(4):1229-38 [10778945.001]
  • [Cites] Nature. 2000 May 25;405(6785):421-4 [10839530.001]
  • [Cites] Cancer Res. 2000 Jun 1;60(11):3043-50 [10850455.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13275-80 [11087869.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2598-603 [11226285.001]
  • [Cites] J Cell Biol. 2001 Aug 20;154(4):799-814 [11514592.001]
  • [Cites] Am J Pathol. 2001 Dec;159(6):2239-48 [11733373.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):303-8 [11756685.001]
  • [Cites] Cancer Res. 2002 Jun 1;62(11):3282-8 [12036946.001]
  • [Cites] Mol Cell. 2002 Oct;10(4):721-33 [12419217.001]
  • [Cites] Cancer Res. 2003 Apr 15;63(8):1748-51 [12702555.001]
  • [Cites] Cell. 2003 Apr 18;113(2):159-70 [12705865.001]
  • [Cites] Gastroenterology. 2003 Aug;125(2):556-71 [12891558.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9968-73 [12909723.001]
  • [Cites] J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):257-65 [12943711.001]
  • [Cites] Nat Med. 2004 Mar;10(3):245-7 [14758356.001]
  • [Cites] Nat Med. 2004 May;10(5):481-3 [15048110.001]
  • [Cites] Cancer Res. 2004 May 1;64(9):3162-70 [15126355.001]
  • [Cites] Trends Pharmacol Sci. 2004 Jun;25(6):331-6 [15165749.001]
  • [Cites] Cancer Cell. 2004 Sep;6(3):285-95 [15380519.001]
  • [Cites] N Engl J Med. 1988 Sep 1;319(9):525-32 [2841597.001]
  • [Cites] Anal Quant Cytol Histol. 1990 Jun;12(3):172-6 [2369470.001]
  • [Cites] Dis Colon Rectum. 1991 Mar;34(3):249-59 [1999132.001]
  • [Cites] Cell. 1994 Dec 30;79(7):1147-56 [8001151.001]
  • [Cites] Am J Pathol. 1996 May;148(5):1567-76 [8623925.001]
  • [Cites] Cell. 1996 Nov 29;87(5):803-9 [8945508.001]
  • [Cites] Diabetes. 1998 Apr;47(4):507-14 [9568680.001]
  • [Cites] Science. 1998 Sep 4;281(5382):1509-12 [9727977.001]
  • [Cites] Oncogene. 1999 Jan 7;18(1):103-15 [9926925.001]
  • [Cites] Nature. 1999 Apr 1;398(6726):422-6 [10201372.001]
  • [Cites] Dis Colon Rectum. 1999 Mar;42(3):386-92 [10223762.001]
  • [Cites] Genes Dev. 1999 Jun 15;13(12):1561-74 [10385625.001]
  • [Cites] Oncogene. 2004 Nov 25;23(55):8992-6 [15480419.001]
  • [Cites] Cell Cycle. 2004 Dec;3(12):1512-5 [15539957.001]
  • [Cites] Pharmacogenet Genomics. 2005 Oct;15(10):713-21 [16141797.001]
  • [Cites] Anticancer Res. 2005 Nov-Dec;25(6B):3781-9 [16309164.001]
  • [Cites] Pharmacogenet Genomics. 2006 Jan;16(1):43-50 [16344721.001]
  • [Cites] Carcinogenesis. 2006 Feb;27(2):232-9 [16141240.001]
  • [Cites] Eur J Surg Oncol. 2006 Mar;32(2):181-5 [16361076.001]
  • (PMID = 16969348.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / PPAR delta; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2360534
  •  go-up   go-down


22. Conio M, Blanchi S, Repici A, Ruggeri C, Fisher DA, Filiberti R: Cap-assisted endoscopic mucosal resection for colorectal polyps. Dis Colon Rectum; 2010 Jun;53(6):919-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Invasive adenocarcinoma was found in 35 patients, of whom 15 underwent surgery.

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20485006.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L: Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr; 2010 May;122 Suppl 2:26-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / surgery. Colorectal Neoplasms / surgery. Prebiotics. Preoperative Care / methods. Probiotics / administration & dosage

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JPEN J Parenter Enteral Nutr. 2007 Mar-Apr;31(2):119-26 [17308252.001]
  • [Cites] Am J Transplant. 2005 Jan;5(1):125-30 [15636620.001]
  • [Cites] Curr Opin Crit Care. 2001 Apr;7(2):92-8 [11373517.001]
  • [Cites] Lancet. 2008 Feb 23;371(9613):651-659 [18279948.001]
  • [Cites] Lancet. 2003 Jun 14;361(9374):2068-77 [12814731.001]
  • [Cites] Ann Surg. 2007 Jun;245(6):1000 [17522529.001]
  • [Cites] Clin Nutr. 2007 Apr;26(2):182-92 [17011083.001]
  • [Cites] Dis Colon Rectum. 1998 Jul;41(7):875-82; discussion 882-3 [9678373.001]
  • [Cites] BMJ. 1998 Apr 25;316(7140):1275-85 [9554897.001]
  • [Cites] Am J Infect Control. 1988 Jun;16(3):128-40 [2841893.001]
  • [Cites] Ann Surg. 2007 Jul;246(1):36-41 [17592288.001]
  • [Cites] Hepatogastroenterology. 2007 Mar;54(74):590-4 [17523328.001]
  • [Cites] Nutrition. 2002 Jul-Aug;18(7-8):609-15 [12093440.001]
  • [Cites] Br J Surg. 2007 May;94(5):546-54 [17443852.001]
  • [Cites] Gut. 1998 Jan;42(1):2-7 [9505873.001]
  • [Cites] Br J Surg. 2002 Sep;89(9):1103-7 [12190674.001]
  • [Cites] Ann Surg. 2008 Mar;247(3):560-1; author reply 561 [18376215.001]
  • [Cites] Dis Colon Rectum. 2005 Aug;48(8):1509-16 [15981065.001]
  • [Cites] Transplantation. 2002 Jul 15;74(1):123-7 [12134110.001]
  • [Cites] Clin Nutr. 2001 Feb;20(1):11-9 [11161538.001]
  • [Cites] Ann Surg. 2006 Nov;244(5):706-14 [17060763.001]
  • [Cites] Clin Nutr. 2004 Oct;23(5):1069-73 [15380897.001]
  • [Cites] Clin Nutr. 1996 Feb;15(1):1-10 [16843987.001]
  • (PMID = 20517667.001).
  • [ISSN] 1613-7671
  • [Journal-full-title] Wiener klinische Wochenschrift
  • [ISO-abbreviation] Wien. Klin. Wochenschr.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] Austria
  • [Chemical-registry-number] 0 / Anthraquinones; 0 / Cathartics; 0 / Electrolytes; 0 / Golytely; 0 / Inflammation Mediators; 0 / Interleukin-6; 0 / Prebiotics; 30IQX730WE / Polyethylene Glycols; 57828-25-8 / X-prep; 9001-32-5 / Fibrinogen; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


24. Liedenbaum MH, de Vries AH, van Rijn AF, Dekker HM, Willemssen FE, van Leerdam ME, van Marrewijk CJ, Fockens P, Bipat S, Bossuyt PM, Dekker E, Stoker J: CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population. Abdom Imaging; 2010 Dec;35(6):661-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: In total 22 of 302 included FOBT positive participants had a carcinoma (7%) and 137 had an adenoma or carcinoma ≥10 mm (45%).
  • CTC sensitivity for carcinoma was 95% with one rectal carcinoma as false negative finding.

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1999 Mar;172(3):595-9 [10063842.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jun;186(6):1611-7 [16714650.001]
  • [Cites] CA Cancer J Clin. 2006 May-Jun;56(3):143-59; quiz 184-5 [16737947.001]
  • [Cites] Cochrane Database Syst Rev. 2007;(1):CD001216 [17253456.001]
  • [Cites] AJR Am J Roentgenol. 2007 Jul;189(1):W1-3 [17579127.001]
  • [Cites] AJR Am J Roentgenol. 2007 Sep;189(3):672-80 [17715116.001]
  • [Cites] N Engl J Med. 2007 Oct 4;357(14):1403-12 [17914041.001]
  • [Cites] Eur Radiol. 2008 Jan;18(1):32-42 [17404739.001]
  • [Cites] CA Cancer J Clin. 2008 May-Jun;58(3):130-60 [18322143.001]
  • [Cites] AJR Am J Roentgenol. 2008 Jul;191(1):158-67 [18562740.001]
  • [Cites] Gastroenterology. 2008 Jul;135(1):82-90 [18482589.001]
  • [Cites] N Engl J Med. 2008 Sep 18;359(12):1207-17 [18799557.001]
  • [Cites] Gut. 2009 Feb;58(2):241-8 [18852257.001]
  • [Cites] Am J Gastroenterol. 2009 Mar;104(3):739-50 [19240699.001]
  • [Cites] Br J Cancer. 2009 Apr 7;100(7):1103-10 [19337257.001]
  • [Cites] Abdom Imaging. 2009 Mar-Apr;34(2):157-71 [18414934.001]
  • [Cites] JAMA. 2009 Jun 17;301(23):2453-61 [19531785.001]
  • [Cites] Radiol Med. 2009 Jun;114(4):586-94 [19430734.001]
  • [Cites] Gut. 2009 Sep;58(9):1242-9 [19625276.001]
  • [Cites] Eur Radiol. 2010 Feb;20(2):367-76 [19707769.001]
  • [Cites] Gut. 2000 Aug;47(2):251-5 [10896917.001]
  • [Cites] Semin Gastrointest Dis. 2000 Oct;11(4):176-84 [11057945.001]
  • [Cites] Am J Gastroenterol. 2000 Nov;95(11):3053-63 [11095318.001]
  • [Cites] Radiology. 2001 Jun;219(3):693-8 [11376256.001]
  • [Cites] Radiology. 2003 Mar;226(3):653-61 [12601201.001]
  • [Cites] Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43 [14652541.001]
  • [Cites] N Engl J Med. 2003 Dec 4;349(23):2191-200 [14657426.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Apr;2(4):314-21 [15067626.001]
  • [Cites] BMJ. 2004 Jul 17;329(7458):133 [15237087.001]
  • [Cites] Cancer. 1975 Dec;36(6):2251-70 [1203876.001]
  • [Cites] Int J Cancer. 1986 Aug 15;38(2):173-6 [3733258.001]
  • [Cites] N Engl J Med. 1993 Dec 30;329(27):1977-81 [8247072.001]
  • [Cites] BMJ. 1998 Aug 29;317(7158):559-65 [9721111.001]
  • (PMID = 19888629.001).
  • [ISSN] 1432-0509
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 16CHD79MIX / Iothalamic Acid; 967RDI7Z6K / ioxitalamic acid
  • [Other-IDs] NLM/ PMC2980629
  •  go-up   go-down


25. Zissin R, Metser U, Hain D, Even-Sapir E: Mesenteric panniculitis in oncologic patients: PET-CT findings. Br J Radiol; 2006 Jan;79(937):37-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The final diagnosis of malignant mesenteric involvement was based on clinical and imaging follow-up.
  • In seven of the eight patients in group A, a co-existing MP and mesenteric tumour involvement was found: one patient had a recurrent cervical carcinoma and the other six patients had lymphoma.
  • In the last patient of group A, with rectal carcinoma without evidence of recurrence, the mesenteric FDG uptake was a false positive uptake.
  • In all 11 patients with CT findings of MP and negative PET, no malignant involvement of the mesentery was diagnosed.
  • [MeSH-major] Mesentery. Panniculitis, Peritoneal / diagnosis. Peritoneal Neoplasms / diagnosis. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Aged. Aged, 80 and over. Diagnosis, Differential. Female. Fluorodeoxyglucose F18. Humans. Incidental Findings. Male. Middle Aged. Radiopharmaceuticals. Retrospective Studies

  • Genetic Alliance. consumer health - Panniculitis.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16421403.001).
  • [ISSN] 0007-1285
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


26. Macdonald DM, Lin LL, Biehl K, Mutic S, Nantz R, Grigsby PW: Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys; 2008 Jun 1;71(2):618-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
  • PURPOSE: This treatment planning study compared pseudo-step-wedge intensity modulation (PSWIM), intensity-modulated radiation therapy (IMRT), and conventional external irradiation, all combined with brachytherapy, for treatment of patients with cervical cancer.
  • Total doses to Points A, Point P, the bladder point, and the rectal point were calculated.
  • RESULTS: The mean PSWIM total low-dose-rate equivalent dose to Points A and P (97.3 Gy and 65.1 Gy, respectively) was significantly higher, the mean rectal dose was the same, and the mean bladder dose was higher than with IMRT or four-field box.
  • Rectal doses are comparable.
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / radiotherapy. Feasibility Studies. Female. Humans. Lymphatic Irradiation / methods. Middle Aged. Pelvis. Prospective Studies. Radiation Injuries / pathology. Radiotherapy Dosage. Rectum. Urinary Bladder


27. Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA: Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Hum Pathol; 2005 Feb;36(2):170-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
  • Gastrointestinal (GI) tumors continue to be major causes of cancer-related mortality, in part, reflecting metastases that escape detection by histopathology.
  • Guanylyl cyclase C protein was expressed by epithelial cells from the duodenum to the rectum, but not by those in normal esophagus and stomach.
  • [MeSH-major] Adenocarcinoma / enzymology. Gastrointestinal Neoplasms / enzymology. Gastrointestinal Tract / enzymology. Guanylate Cyclase / metabolism. Metaplasia / enzymology. Receptors, Peptide / metabolism
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Humans. Immunoenzyme Techniques. Intestinal Mucosa / enzymology. Intestinal Mucosa / pathology. RNA, Messenger / metabolism. RNA, Neoplasm / analysis. Receptors, Guanylate Cyclase-Coupled. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15754294.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA75123; United States / NCI NIH HHS / CA / CA79663; United States / NCI NIH HHS / CA / CA95026; United States / NCI NIH HHS / CA / R01 CA075123-06; United States / NIGMS NIH HHS / GM / R01 GM050290-05
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Receptors, Peptide; EC 4.6.1.2 / Guanylate Cyclase; EC 4.6.1.2 / Receptors, Guanylate Cyclase-Coupled; EC 4.6.1.2 / enterotoxin receptor
  •  go-up   go-down


28. Kam MH, Wong DC, Siu S, Stevenson AR, Lai J, Phillips GE: Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer. Br J Surg; 2010 Feb;97(2):266-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer.
  • BACKGROUND: : This study represents an initial experience with combined magnetic resonance imaging (MRI) and [(18)F]fluorodeoxyglucose positron emission tomography (FDG PET) (MRI-PET fusion) in the primary staging of rectal carcinoma.
  • METHODS: : A retrospective analysis of data recorded on patients with rectal cancer was undertaken.
  • RESULTS: : Twenty-three patients with rectal carcinoma (15 men), of median age 60 (range 46-75) years, were enrolled.
  • CONCLUSION: : MRI-PET fusion adds little to conventional investigations for staging rectal carcinoma.
  • [MeSH-major] Fluorodeoxyglucose F18. Magnetic Resonance Imaging / methods. Positron-Emission Tomography / methods. Radiopharmaceuticals. Rectal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
  • [CommentIn] Br J Surg. 2010 Jul;97(7):1151; author reply 1151 [20632294.001]
  • (PMID = 20035542.001).
  • [ISSN] 1365-2168
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


29. Topkan E, Karaoglu A: Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology; 2006;71(5-6):354-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
  • METHODS: Forty-two rectal carcinoma (T(3-4)N(0-2)M(0)) patients with grade 2 or 3 diarrhea refractory to loperamide were enrolled to receive octreotide.
  • [MeSH-major] Carcinoma / drug therapy. Carcinoma / radiotherapy. Diarrhea / drug therapy. Loperamide / therapeutic use. Octreotide / therapeutic use. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Diarrhea.
  • MedlinePlus Health Information. consumer health - Diarrhea.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 S. Karger AG, Basel.
  • (PMID = 17873499.001).
  • [ISSN] 1423-0232
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 6X9OC3H4II / Loperamide; RWM8CCW8GP / Octreotide; U3P01618RT / Fluorouracil
  •  go-up   go-down


30. Buchmann P, Dinçler S: [Progress of the laparoscopic colorectal surgery with special consideration regarding cancer treatment]. Praxis (Bern 1994); 2006 Apr 26;95(17):663-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Progress of the laparoscopic colorectal surgery with special consideration regarding cancer treatment].
  • Randomized studies comparing laparoscopic interventions and open surgery showed no difference in the long-term results of colon-carcinoma.
  • For experienced surgeons this is also the case for rectum-carcinoma.
  • [MeSH-minor] Animals. Clinical Competence. Cost-Benefit Analysis. Diffusion of Innovation. Education, Medical, Continuing / trends. Evidence-Based Medicine. Forecasting. General Surgery / education. Germany. Humans. Neoplasm Seeding

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16686322.001).
  • [ISSN] 1661-8157
  • [Journal-full-title] Praxis
  • [ISO-abbreviation] Praxis (Bern 1994)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


31. Kang SB, Park JS, Kim DW, Lee TG: Intraoperative technical difficulty during laparoscopy-assisted surgery as a prognostic factor for colorectal cancer. Dis Colon Rectum; 2010 Oct;53(10):1400-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraoperative technical difficulty during laparoscopy-assisted surgery as a prognostic factor for colorectal cancer.
  • BACKGROUND: Laparoscopy-assisted surgery has technical drawbacks compared with open surgery, although laparoscopic surgery has become widely adopted with evidence of oncological safety for colon cancer treatment.
  • The oncological risk of technical difficulties during laparoscopic surgery for colorectal cancer has not been previously reported.
  • We aimed to investigate whether a technical difficulty encountered during laparoscopic surgery can be considered a recurrence-related factor for colorectal cancer.
  • METHODS: Data from 427 patients who underwent laparoscopic surgery for colorectal cancer between May 2003 and December 2007 were analyzed.
  • Technical difficulties were encountered more frequently in men compared with women (13.5% vs 6.0%, P = .013), and for cancers located in the mid and low rectum, splenic flexure, and descending colon.
  • [MeSH-major] Adenocarcinoma / surgery. Colorectal Neoplasms / surgery. Intraoperative Complications. Laparoscopy / adverse effects. Neoplasm Recurrence, Local / epidemiology
  • [MeSH-minor] Adult. Aged. Cohort Studies. Female. Humans. Male. Middle Aged. Neoplasm Staging. Proportional Hazards Models. Retrospective Studies. Risk Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dis Colon Rectum. 2011 Jun;54(6):e204; author reply e204-5 [21552042.001]
  • (PMID = 20847622.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Moral M, Fdez-Aceñero MA, Cuberes R, Suárez A: Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma. Pathol Res Pract; 2009;205(10):695-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors influencing histological response after neoadjuvant chemoradiation therapy for rectal carcinoma.
  • Neoadjuvant chemoradiation therapy is one of the standard therapeutic regimens for rectal carcinoma.
  • In our series of patients with rectal carcinoma receiving preoperative chemoradiation therapy, few factors were predictive of a histological response.
  • [MeSH-major] Biomarkers, Tumor / analysis. Neoadjuvant Therapy. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Age Factors. Antineoplastic Agents / therapeutic use. Carcinoembryonic Antigen / blood. Combined Modality Therapy. Cyclin D1 / biosynthesis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Proto-Oncogene Proteins c-bcl-2 / biosynthesis. Radiotherapy. Risk Factors. Treatment Outcome. Tumor Suppressor Protein p53 / biosynthesis. Ubiquitin-Protein Ligases / biosynthesis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19446404.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Tumor Suppressor Protein p53; 136601-57-5 / Cyclin D1; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


33. Ushigome T, Kawahara H, Kobayashi T, Kobayashi S, Kashiwagi H, Yanaga K: Where should the specimen be excised for the chemosensitivity of colorectal cancer to 5-fluorouracil? Hepatogastroenterology; 2010 Sep-Oct;57(102-103):1090-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Where should the specimen be excised for the chemosensitivity of colorectal cancer to 5-fluorouracil?
  • BACKGROUND/AIMS: The aim of this study was to reveal the relationship between the expression of dihydropyrimidine dehydrogenase (DPD) and thymidylate synthase (TS) in normal tissue, lymph nodes or tumors and as a prognostic indicator in T3 rectal carcinoma.
  • METHODOLOGY: This study was prospectively conducted on 20 consecutive patients with T3 rectal cancer for whom surgically curative resection was performed between 2000 and 2002.
  • CONCLUSIONS: For the chemosensitivity of colorectal cancer to 5-Fluorouracil, the specimen should be excised from the invasive front of the tumor, and TS expression should be evaluated in it.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Fluorouracil / therapeutic use. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Dihydrouracil Dehydrogenase (NADP) / metabolism. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / enzymology. Prospective Studies. Thymidylate Synthase / metabolism

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21410037.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; EC 1.3.1.2 / Dihydrouracil Dehydrogenase (NADP); EC 2.1.1.45 / Thymidylate Synthase; U3P01618RT / Fluorouracil
  •  go-up   go-down


34. Sideris L, Mitchell A, Drolet P, Leblanc G, Leclerc YE, Dubé P: Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix. Can J Surg; 2009 Apr;52(2):135-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma, Mucinous / therapy. Antineoplastic Agents / administration & dosage. Appendiceal Neoplasms / pathology. Hyperthermia, Induced. Peritoneal Neoplasms / therapy

  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Anat Pathol. 2005 Nov;12(6):291-311 [16330927.001]
  • [Cites] Jpn J Clin Oncol. 2005 Sep;35(9):531-5 [16027146.001]
  • [Cites] J Oncol Pharm Pract. 2005 Sep;11(3):111-9 [16390599.001]
  • [Cites] Br J Cancer. 2006 May 8;94(9):1287-92 [16622455.001]
  • [Cites] Am J Surg Pathol. 2006 May;30(5):551-9 [16699309.001]
  • [Cites] Eur J Surg Oncol. 2006 Aug;32(6):607-13 [16621432.001]
  • [Cites] Cancer Invest. 2006 Mar;24(2):154-9 [16537184.001]
  • [Cites] Ann Surg Oncol. 1999 Dec;6(8):727-31 [10622499.001]
  • [Cites] Langenbecks Arch Surg. 1999 Dec;384(6):576-87 [10654274.001]
  • [Cites] J Chir (Paris). 1999 Dec;136(6):341-7 [10675825.001]
  • [Cites] Br J Surg. 2000 Aug;87(8):1006-15 [10931042.001]
  • [Cites] Ann Oncol. 2000 Nov;11(11):1477-83 [11142489.001]
  • [Cites] Gynecol Obstet Invest. 2001;51(2):73-80 [11223697.001]
  • [Cites] Br J Surg. 2001 Mar;88(3):458-63 [11260116.001]
  • [Cites] Eur J Cancer. 2001 May;37(8):979-84 [11334722.001]
  • [Cites] Int J Surg Investig. 2000;1(5):431-9 [11341599.001]
  • [Cites] Cancer. 2001 Jul 1;92(1):85-91 [11443613.001]
  • [Cites] Br J Surg. 2001 Aug;88(8):1130 [11488802.001]
  • [Cites] Int J Cancer. 2001 Oct 20;96(5):297-304 [11582582.001]
  • [Cites] Postgrad Med J. 2002 Mar;78(917):170-2 [11884702.001]
  • [Cites] Ann Oncol. 2002 Feb;13(2):267-72 [11886004.001]
  • [Cites] Tumori. 2002 Sep-Oct;88(5):370-5 [12487553.001]
  • [Cites] Gastroenterol Clin Biol. 2003 Apr;27(4):407-12 [12759682.001]
  • [Cites] Int J Gynecol Cancer. 2003 Jul-Aug;13(4):413-8 [12911716.001]
  • [Cites] Eur J Surg Oncol. 2003 Oct;29(8):682-8 [14511618.001]
  • [Cites] Eur J Surg Oncol. 2004 Apr;30(3):280-5 [15028309.001]
  • [Cites] Br J Surg. 2004 Apr;91(4):455-6 [15048746.001]
  • [Cites] Ann Oncol. 2004 Oct;15(10):1558-65 [15367418.001]
  • [Cites] Ugeskr Laeger. 2004 Aug 23;166(35):2979-81 [15387006.001]
  • [Cites] Dis Colon Rectum. 1987 Oct;30(10):772-9 [2820671.001]
  • [Cites] Cancer Res. 1989 Jun 15;49(12):3380-4 [2720692.001]
  • [Cites] Eur J Cancer Clin Oncol. 1989 Dec;25(12):1857-66 [2632267.001]
  • [Cites] Ann Surg. 1994 Feb;219(2):109-11 [8129480.001]
  • [Cites] Am J Surg Pathol. 1994 Jun;18(6):591-603 [8179074.001]
  • [Cites] Ann Surg. 1995 Jan;221(1):29-42 [7826158.001]
  • [Cites] Cancer Treat Res. 1996;81:105-19 [8834579.001]
  • [Cites] Eur J Cancer. 1996 Sep;32A(10):1727-33 [8983281.001]
  • [Cites] J Cancer Res Clin Oncol. 1997;123(1):6-12 [8996534.001]
  • [Cites] Eur J Surg Oncol. 1997 Aug;23(4):317-21 [9315060.001]
  • [Cites] Rev Med Interne. 1997;18(10):769-75 [9500010.001]
  • [Cites] Semin Surg Oncol. 1998 Apr-May;14(3):254-61 [9548609.001]
  • [Cites] Anat Pathol. 1997;2:197-226 [9575376.001]
  • [Cites] Gastroenterologist. 1998 Jun;6(2):147-50 [9660531.001]
  • [Cites] Br J Surg. 1999 Jun;86(6):842 [10419331.001]
  • [Cites] Ned Tijdschr Geneeskd. 1999 Sep 11;143(37):1863-8 [10526600.001]
  • [Cites] Ann Surg. 2005 Feb;241(2):300-8 [15650641.001]
  • [Cites] Clin Colorectal Cancer. 2005 Jan;4(5):296-9 [15663831.001]
  • [Cites] Zentralbl Chir. 2005 Apr;130(2):177-80 [15849666.001]
  • [Cites] Acta Chir Belg. 2005 Apr;105(2):127-33 [15906901.001]
  • [Cites] Hepatogastroenterology. 2005 May-Jun;52(63):812-6 [15966210.001]
  • [Cites] Lancet Oncol. 2006 Jan;7(1):69-76 [16389186.001]
  • (PMID = 19399209.001).
  • [ISSN] 1488-2310
  • [Journal-full-title] Canadian journal of surgery. Journal canadien de chirurgie
  • [ISO-abbreviation] Can J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 50SG953SK6 / Mitomycin; 7673326042 / irinotecan; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin
  • [Other-IDs] NLM/ PMC2663512
  •  go-up   go-down


35. Eriksen MT, Wibe A, Haffner J, Wiig JN, Norwegian Rectal Cancer Group: Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum; 2007 Feb;50(2):156-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
  • METHODS: This was a national cohort study of 2,460 patients with pT3 rectal adenocarcinoma, undergoing major surgery without preoperative radiotherapy from November 1993 to December 2002.
  • [MeSH-major] Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Fluorouracil / administration & dosage. Humans. Levamisole / administration & dosage. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Norway. Patient Selection. Prognosis. Proportional Hazards Models. Radiotherapy, Adjuvant. Registries. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17180256.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 2880D3468G / Levamisole; U3P01618RT / Fluorouracil
  •  go-up   go-down


36. Yamamoto S, Akasu T, Fujita S, Moriya Y: Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? Hepatogastroenterology; 2005 Mar-Apr;52(62):444-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
  • BACKGROUND/AIMS: This study was undertaken to investigate whether it will be possible to reduce the times and types of postoperative examinations for surveillance in patients with UICC stage I colorectal carcinoma.
  • METHODOLOGY: A review was performed of 541 patients who underwent curative resection for UICC stage I colorectal carcinoma between January, 1985 and December, 1998.
  • Cancer-specific survival rates at 5 years were 99.3% and 97.6%, respectively (p=0.0354).
  • Recurrences occurred more frequently in patients with lower rectal carcinoma (p=0.0415).
  • CONCLUSIONS: The incidence of recurrence was low after curative surgery in patients with UICC stage I colorectal carcinoma, and it is therefore possible to reduce times and types of postoperative examinations.
  • [MeSH-major] Carcinoembryonic Antigen / blood. Carcinoma / surgery. Colorectal Neoplasms / surgery. Neoplasm Recurrence, Local / blood. Neoplasm Recurrence, Local / diagnosis. Population Surveillance
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Postoperative Period. Retrospective Studies. Survival Analysis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15816454.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  •  go-up   go-down


37. Grillo-Ruggieri F, Mantello G, Berardi R, Cardinali M, Fenu F, Iovini G, Montisci M, Fabbietti L, Marmorale C, Guerrieri M, Saba V, Bearzi I, Mattioli R, Bonsignori M, Cascinu S: Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum; 2007 Oct;50(10):1594-603
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
  • PURPOSE: The aim of this study was to evaluate downstaging as primary end point, and progression-free survival and overall survival as secondary end points, in rectal adenocarcinoma patients treated with preoperative chemoradiation.
  • METHODS: One hundred and thirty-six extraperitoneal adenocarcinoma patients (33 low rectum T2, 74 T3, 29 T4 [without sacral invasion], 25 with mucinous subtype) were treated with posterior pelvis preoperative radiotherapy (5040 cGy total dose, 180 cGy/fr, 5 fr/w, 10-15 MV linac X-rays) and concomitant 5-fluorouracil-based chemotherapy.
  • There were no significant differences in overall survival and progression-free survival between adenocarcinoma and mucinous subtype.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / therapy. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antimetabolites, Antineoplastic / therapeutic use. Chemotherapy, Adjuvant. Digestive System Surgical Procedures. Disease-Free Survival. Female. Fluorouracil / therapeutic use. Humans. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Survival Rate

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17846841.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


38. Grade M, Hörmann P, Becker S, Hummon AB, Wangsa D, Varma S, Simon R, Liersch T, Becker H, Difilippantonio MJ, Ghadimi BM, Ried T: Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res; 2007 Jan 1;67(1):41-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Previously, we had conducted a similar analysis of primary rectal carcinomas.
  • The systematic comparison of colon and rectal carcinomas revealed a significant overlap of genomic imbalances and transcriptional deregulation, including activation of the Wnt/beta-catenin signaling cascade, suggesting similar pathogenic pathways.
  • [MeSH-major] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Aneuploidy. Colonic Neoplasms / genetics. Colonic Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Colon / metabolism. Colon / physiology. Female. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Genome, Human. Humans. Intestinal Mucosa / metabolism. Intestinal Mucosa / physiology. Lymphatic Metastasis. Male. Middle Aged. Multigene Family. Neoplasm Staging. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17210682.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 CA999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS663105; NLM/ PMC4721580
  •  go-up   go-down


39. Ribatti D, Guidolin D, Marzullo A, Nico B, Annese T, Benagiano V, Crivellato E: Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol; 2010 Aug;91(4):350-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cells and angiogenesis in gastric carcinoma.
  • Previous studies have shown that increased vascularity is associated with haematogenous metastasis and poor prognosis in gastric cancer.
  • The role of mast cells in gastric cancer angiogenesis has not been clarified completely.
  • In this study, we correlated microvascular density and tryptase- and chymase-positive mast cells with histopathological type in gastric cancer.
  • The results showed that stage IV gastric carcinoma has a higher degree of vascularization than other stages and that both tryptase- and chymase-positive mast cells increase in parallel with malignancy grade even if the density of chymase-positive mast cells was significantly lower than the density of tryptase-positive mast cells and is highly correlated with the extent of angiogenesis.
  • This study has demonstrated that mast cell density correlates with angiogenesis and progression of patients with gastric carcinoma.
  • Understanding the mechanisms of gastric cancer angiogenesis provides a basis for a rational approach to the development of an antiangiogenic therapy in patients with this malignancy.
  • [MeSH-major] Adenocarcinoma / blood supply. Adenocarcinoma / pathology. Mast Cells / pathology. Microvessels / pathology. Neovascularization, Pathologic / pathology. Stomach Neoplasms / blood supply. Stomach Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Antigens, CD31 / analysis. Chymases / analysis. Female. Gastrectomy. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Tryptases / analysis

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1999 Oct 15;86(8):1455-62 [10526273.001]
  • [Cites] Methods Mol Biol. 2006;315:53-62 [16110148.001]
  • [Cites] Int J Cancer. 2000 Jan 15;85(2):171-5 [10629073.001]
  • [Cites] Br J Cancer. 2000 Jan;82(1):167-70 [10638985.001]
  • [Cites] Virchows Arch. 2000 Mar;436(3):243-8 [10782883.001]
  • [Cites] Ann Thorac Surg. 2000 Jun;69(6):1686-90 [10892907.001]
  • [Cites] Surgery. 2000 Sep;128(3):408-16 [10965312.001]
  • [Cites] Hum Pathol. 2000 Aug;31(8):955-60 [10987256.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):2145-53 [11280779.001]
  • [Cites] J Histochem Cytochem. 2001 Aug;49(8):1061-2 [11457936.001]
  • [Cites] J Clin Pathol. 2001 Dec;54(12):940-4 [11729214.001]
  • [Cites] Leukemia. 2002 Sep;16(9):1680-4 [12200681.001]
  • [Cites] World J Gastroenterol. 2002 Dec;8(6):994-8 [12439912.001]
  • [Cites] Histopathology. 2003 Mar;42(3):246-50 [12605644.001]
  • [Cites] Eur J Cancer. 2003 Mar;39(5):666-74 [12628847.001]
  • [Cites] Eur J Clin Invest. 2003 May;33(5):420-5 [12760367.001]
  • [Cites] Leukemia. 2003 Jul;17(7):1428-30 [12835741.001]
  • [Cites] Eur J Haematol. 2003 Aug;71(2):137-9 [12890156.001]
  • [Cites] Mol Cancer Ther. 2004 Sep;3(9):1041-8 [15367698.001]
  • [Cites] Surg Gynecol Obstet. 1966 Jul;123(1):3-9 [5947123.001]
  • [Cites] Pediatrics. 1982 Jul;70(1):48-51 [7088632.001]
  • [Cites] J Clin Invest. 1989 Nov;84(5):1657-62 [2553780.001]
  • [Cites] J Biol Chem. 1994 Apr 1;269(13):9416-9 [8144524.001]
  • [Cites] J Clin Oncol. 1995 Feb;13(2):477-81 [7531224.001]
  • [Cites] J Biol Chem. 1995 Mar 3;270(9):4689-96 [7876240.001]
  • [Cites] Dis Colon Rectum. 1995 Mar;38(3):290-3 [7882795.001]
  • [Cites] Cancer. 1996 Mar 1;77(5):858-63 [8608475.001]
  • [Cites] Cancer Res. 1996 Jun 1;56(11):2671-6 [8653715.001]
  • [Cites] J Clin Oncol. 1997 Feb;15(2):826-32 [9053510.001]
  • [Cites] Br J Cancer. 1997;75(4):566-71 [9052412.001]
  • [Cites] J Clin Invest. 1997 Jun 1;99(11):2691-700 [9169499.001]
  • [Cites] J Surg Oncol. 1997 Aug;65(4):232-6 [9274786.001]
  • [Cites] Am J Pathol. 1998 Jan;152(1):93-100 [9422527.001]
  • [Cites] Clin Cancer Res. 1998 Feb;4(2):429-34 [9516932.001]
  • [Cites] Nat Clin Pract Oncol. 2005 Nov;2(11):562-77 [16270097.001]
  • [Cites] Am J Obstet Gynecol. 2005 Dec;193(6):1961-5 [16325597.001]
  • [Cites] Int J Mol Med. 2006 Jun;17(6):981-7 [16685405.001]
  • [Cites] Oncogene. 2006 Jul 20;25(31):4257-66 [16518413.001]
  • [Cites] J Clin Oncol. 2006 Nov 20;24(33):5201-6 [17114652.001]
  • [Cites] Leukemia. 2007 Jan;21(1):44-52 [16990761.001]
  • [Cites] Neurobiol Aging. 2008 Jun;29(6):926-36 [17258840.001]
  • [Cites] Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):20-4 [19136773.001]
  • [Cites] Int Rev Cell Mol Biol. 2009;275:89-131 [19491054.001]
  • [Cites] J Cell Mol Med. 2009 Sep;13(9A):2822-33 [19538473.001]
  • [Cites] Br J Cancer. 1998 Jun;77(11):1900-6 [9667666.001]
  • [Cites] Int J Cancer. 1998 Sep 11;77(6):933-6 [9714067.001]
  • [Cites] Clin Cancer Res. 1996 Oct;2(10):1679-84 [9816116.001]
  • [Cites] Br J Cancer. 1999 Feb;79(3-4):451-5 [10027312.001]
  • [Cites] Clin Exp Allergy. 2004 Nov;34(11):1660-4 [15544587.001]
  • [Cites] Anticancer Res. 2005 Jan-Feb;25(1A):17-22 [15816514.001]
  • [Cites] Br J Cancer. 1999 Oct;81(4):647-53 [10574250.001]
  • (PMID = 20412338.001).
  • [ISSN] 1365-2613
  • [Journal-full-title] International journal of experimental pathology
  • [ISO-abbreviation] Int J Exp Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD31; EC 3.4.21.39 / Chymases; EC 3.4.21.59 / Tryptases
  • [Other-IDs] NLM/ PMC2962893
  •  go-up   go-down


40. Gosens MJ, Dresen RC, Rutten HJ, Nieuwenhuijzen GA, van der Laak JA, Martijn H, Tan-Go I, Nagtegaal ID, van den Brule AJ, van Krieken JH: Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours. Ann Oncol; 2008 Dec;19(12):2026-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.
  • BACKGROUND: Not all patients with locally advanced rectal cancer (LARC) respond equally to neo-adjuvant radiochemotherapy (RCT).
  • Patients with highly apoptotic less advanced rectal cancers do not benefit from short-term radiotherapy.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Immunohistochem Mol Morphol. 2001 Dec;9(4):329-34 [11759059.001]
  • [Cites] Psychol Bull. 1968 Oct;70(4):213-20 [19673146.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):294-303 [11872273.001]
  • [Cites] Arch Pathol Lab Med. 2002 Jun;126(6):702-5 [12033959.001]
  • [Cites] Gastroenterology. 2002 Jun;122(7):1800-7 [12055587.001]
  • [Cites] Strahlenther Onkol. 2002 Aug;178(8):426-35 [12240548.001]
  • [Cites] Science. 2003 May 16;300(5622):1155-9 [12750523.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):434-43 [12957255.001]
  • [Cites] Histopathology. 2004 Jan;44(1):9-17 [14717663.001]
  • [Cites] Biometrics. 1977 Jun;33(2):363-74 [884196.001]
  • [Cites] Science. 1991 Jul 5;253(5015):49-53 [1905840.001]
  • [Cites] J Clin Oncol. 1992 Jan;10(1):79-84 [1727928.001]
  • [Cites] Nature. 1993 Apr 29;362(6423):847-9 [8479522.001]
  • [Cites] Cancer Res. 1994 Feb 1;54(3):614-7 [8306319.001]
  • [Cites] Eur J Cancer. 1995 Sep;31A(10):1580-5 [7488405.001]
  • [Cites] Nature. 1997 Jun 19;387(6635):773-6 [9194558.001]
  • [Cites] Biochem Pharmacol. 1998 Apr 1;55(7):1091-7 [9605432.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):585-91 [9635706.001]
  • [Cites] Exp Cell Res. 1998 Jun 15;241(2):394-403 [9637781.001]
  • [Cites] Strahlenther Onkol. 1998 Jun;174(6):295-9 [9645209.001]
  • [Cites] Eur J Cancer. 1998 Jul;34(8):1274-81 [9849491.001]
  • [Cites] J Clin Oncol. 2005 Mar 20;23(9):1847-58 [15774778.001]
  • [Cites] J Clin Oncol. 2005 Dec 1;23(34):8688-96 [16246976.001]
  • [Cites] Eur J Surg Oncol. 2006 Feb;32(1):55-64 [16324817.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1719-26 [16985035.001]
  • [Cites] Clin Cancer Res. 2006 Nov 1;12(21):6432-6 [17085656.001]
  • [Cites] J Clin Oncol. 1999 Aug;17(8):2396 [10561302.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):425-33 [10802370.001]
  • [Cites] Strahlenther Onkol. 2000 Apr;176(4):161-7 [10812388.001]
  • [Cites] Dis Colon Rectum. 2000 Sep;43(9):1227-36 [11005488.001]
  • [Cites] Cancer. 2001 May 15;91(10):1870-5 [11346868.001]
  • [Cites] Clin Cancer Res. 2007 May 15;13(10):2955-60 [17504996.001]
  • [Cites] Clin Cancer Res. 2007 Oct 1;13(19):5810-5 [17908973.001]
  • [Cites] Int J Colorectal Dis. 2008 Jan;23(1):21-7 [17805550.001]
  • [Cites] Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6617-23 [18006762.001]
  • [Cites] Am J Surg Pathol. 2002 Mar;26(3):312-9 [11859202.001]
  • (PMID = 18664561.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / SERPIN-B5; 0 / Serpins; 0 / Tumor Suppressor Protein p53; 0 / bcl-2-Associated X Protein; EC 1.14.99.1 / Cyclooxygenase 2
  • [Other-IDs] NLM/ PMC2733117
  •  go-up   go-down


41. Miyagi M, Aoyagi K, Kato S, Shirouzu K: The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer. Int J Clin Oncol; 2007 Feb;12(1):17-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer.
  • METHODS: We established a high-potential peritoneal metastasis cell line (MKN-45P), using the gastric cancer cell line MKN-45, and developed a peritoneal metastasis model in nude mice.
  • [MeSH-major] Adenocarcinoma / secondary. Adenoviridae. Peritoneal Neoplasms / secondary. Stomach Neoplasms / pathology. Tissue Inhibitor of Metalloproteinase-1 / genetics
  • [MeSH-minor] Animals. Cell Line, Tumor. Cell Proliferation. Disease Models, Animal. Female. Gene Expression Regulation, Neoplastic. Genetic Vectors. Humans. Immunohistochemistry. Mice. Mice, Inbred BALB C. Mice, Nude. Middle Aged. Neoplasm Invasiveness. Neovascularization, Pathologic / prevention & control. Time Factors. Transfection

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Cellosaurus - a cell line knowledge resource. culture/stock collections - Cellosaurus - a cell line knowledge resource .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochem J. 2003 Jun 15;372(Pt 3):767-74 [12639219.001]
  • [Cites] J Cell Physiol. 1994 Jul;160(1):194-202 [7517405.001]
  • [Cites] Dis Colon Rectum. 2005 Apr;48(4):700-10 [15906450.001]
  • [Cites] Gut. 1998 Dec;43(6):791-7 [9824606.001]
  • [Cites] Cancer. 1996 Apr 15;77(8 Suppl):1676-80 [8608561.001]
  • [Cites] J Biol Chem. 1996 Sep 27;271(39):23938-45 [8798626.001]
  • [Cites] J Cell Biol. 1992 Aug;118(3):727-39 [1639854.001]
  • [Cites] Gastric Cancer. 2000 Sep 29;3(2):63-70 [11984713.001]
  • [Cites] J Natl Cancer Inst. 1992 Jul 1;84(13):1017-22 [1318976.001]
  • [Cites] Mol Cancer Res. 2006 Mar;4(3):209-20 [16547158.001]
  • [Cites] J Natl Cancer Inst. 1990 Apr 4;82(7):589-95 [2156082.001]
  • [Cites] Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17 [15000152.001]
  • [Cites] Clin Exp Metastasis. 2000;18(2):111-20 [11235986.001]
  • [Cites] Nature. 1997 Sep 4;389(6646):77-81 [9288970.001]
  • [Cites] J Biol Chem. 1999 Jul 30;274(31):21491-4 [10419448.001]
  • [Cites] Cancer Res. 1986 Jan;46(1):1-7 [2998604.001]
  • [Cites] Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83 [10708863.001]
  • [Cites] Oncol Rep. 2005 Jan;13(1):115-20 [15583811.001]
  • [Cites] J Natl Cancer Inst. 1994 Feb 16;86(4):299-304 [8158685.001]
  • [Cites] FASEB J. 1991 May;5(8):2145-54 [1850705.001]
  • [Cites] J Urol. 2005 Jan;173(1):73-8 [15592032.001]
  • [Cites] Expert Rev Mol Med. 2003 Sep 22;5(23):1-39 [14585170.001]
  • [Cites] Invasion Metastasis. 1989;9(6):391-405 [2689386.001]
  • [Cites] FEBS Lett. 1992 Feb 17;298(1):29-32 [1544418.001]
  • [Cites] Biochemistry. 1991 Aug 20;30(33):8097-102 [1868085.001]
  • [Cites] Science. 1989 Feb 17;243(4893):947-50 [2465572.001]
  • [Cites] Int J Oncol. 1996 Apr;8(4):795-802 [21544429.001]
  • [Cites] Cancer Res. 1993 Mar 15;53(6):1397-402 [8443819.001]
  • [Cites] Bioessays. 1992 Jul;14(7):455-63 [1445287.001]
  • [Cites] Cancer Res. 1988 Oct 1;48(19):5539-45 [3416307.001]
  • [Cites] Cancer Res. 1999 Dec 15;59(24):6267-75 [10626822.001]
  • [Cites] Eur J Biochem. 1997 Feb 15;244(1):81-8 [9063449.001]
  • [Cites] Biochim Biophys Acta. 2004 Dec 17;1705(2):69-89 [15588763.001]
  • [Cites] Eur J Cell Biol. 1997 Oct;74(2):111-22 [9352216.001]
  • [Cites] J Vet Med Sci. 2006 Feb;68(2):105-11 [16520530.001]
  • [Cites] Surg Today. 2000;30(7):614-21 [10930227.001]
  • [Cites] In Vivo. 1996 Mar-Apr;10(2):137-44 [8744792.001]
  • [Cites] J Clin Invest. 1998 Dec 1;102(11):2002-10 [9835626.001]
  • [Cites] Cancer Res. 1992 Feb 1;52(3):701-8 [1732058.001]
  • [Cites] EMBO J. 1995 Mar 1;14(5):908-17 [7534227.001]
  • [Cites] Ann Clin Lab Sci. 2006 Winter;36(1):23-30 [16501233.001]
  • (PMID = 17380436.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Tissue Inhibitor of Metalloproteinase-1
  •  go-up   go-down


42. Metzger PP, Slappy AL, Chua HK, Menke DM: Adenocarcinoma developing at an ileostomy: report of a case and review of the literature. Dis Colon Rectum; 2008 May;51(5):604-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma developing at an ileostomy: report of a case and review of the literature.
  • Primary adenocarcinoma of a permanent ileostomy is a rare and unusual complication.
  • We report a case of primary adenocarcinoma arising at an ileostomy site 46 years after total proctocolectomy for Crohn's colitis.
  • Based on the results of this case and literature review, we concur with the previously reported theory that the etiology of this phenomenon is likely the result of colonic metaplasia in the ileal mucosa, which eventually progresses to carcinoma.
  • [MeSH-major] Adenocarcinoma / etiology. Colitis, Ulcerative / surgery. Ileal Neoplasms / etiology. Ileostomy

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18306002.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 38
  •  go-up   go-down


43. Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg; 2005 Nov;242(5):684-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
  • OBJECTIVE: We sought to quantitatively and objectively evaluate histomorphologic tumor regression and establish a relevant prognostic regression classification system for esophageal cancer patients receiving neoadjuvant radiochemotherapy.
  • CONCLUSIONS: Histomorphologic tumor regression and lymph node status (ypN) were significant prognostic parameters for patients with complete resections (R0) following neoadjuvant radiochemotherapy for esophageal cancer.
  • [MeSH-major] Adenocarcinoma / secondary. Carcinoma, Squamous Cell / secondary. Esophageal Neoplasms / pathology. Esophageal Neoplasms / therapy. Lymph Nodes / pathology. Neoadjuvant Therapy / methods
  • [MeSH-minor] Adult. Age Factors. Aged. Chemotherapy, Adjuvant. Cohort Studies. Esophagectomy / methods. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Probability. Prognosis. Proportional Hazards Models. Prospective Studies. Radiotherapy, Adjuvant. Risk Assessment. Sex Factors. Survival Analysis


44. Liang XM, Tang GY, Cheng YS, Zhou B: Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging. World J Gastroenterol; 2009 May 7;15(17):2139-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging.
  • AIM: To establish a rabbit rectal VX2 carcinoma model for the study of rectal carcinoma.
  • METHODS: A suspension of VX2 cells was injected into the rectum wall under the guidance of X-ray fluoroscopy.
  • CT scanning showed low-density foci of the tumor in the rectum wall, while enhanced CT scanning demonstrated asymmetrical intensification in tumor foci.
  • CONCLUSION: The rabbit rectal VX2 carcinoma model we established has a high stability, and can be used in the study of rectal carcinoma.
  • [MeSH-major] Disease Models, Animal. Magnetic Resonance Imaging. Rectal Neoplasms / pathology. Tomography, X-Ray Computed
  • [MeSH-minor] Animals. Humans. Neoplasm Transplantation. Rabbits

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 2003 Mar;90(3):355-64 [12594673.001]
  • [Cites] Ann Oncol. 2005;16 Suppl 1:i18-9 [15888738.001]
  • [Cites] Ann Oncol. 2005;16 Suppl 1:i20-1 [15888739.001]
  • [Cites] Br J Radiol. 2005;78 Spec No 2:S117-27 [16306634.001]
  • [Cites] J Gastrointest Surg. 2005 Dec;9(9):1222-7; discussion 1227-8 [16332477.001]
  • [Cites] Eur Radiol. 2006 May;16(5):972-80 [16416276.001]
  • [Cites] Radiographics. 2006 May-Jun;26(3):701-14 [16702449.001]
  • [Cites] Histol Histopathol. 2007 Jan;22(1):61-77 [17128412.001]
  • [Cites] Radiology. 2007 Apr;243(1):132-9 [17329685.001]
  • [Cites] Radiology. 2007 Jun;243(3):744-51 [17463134.001]
  • [Cites] Br J Surg. 2007 Aug;94(8):1014-9 [17436337.001]
  • [Cites] J Comput Assist Tomogr. 2007 Jul-Aug;31(4):569-71 [17882033.001]
  • [Cites] Ai Zheng. 2007 Sep;26(9):942-6 [17927849.001]
  • [Cites] Cancer Res. 2007 Oct 15;67(20):9721-30 [17942902.001]
  • [Cites] J Comput Assist Tomogr. 2007 Nov-Dec;31(6):831-9 [18043344.001]
  • [Cites] Br J Radiol. 2008 Jan;81(961):10-9 [17967848.001]
  • [Cites] Br J Surg. 2008 Feb;95(2):229-36 [17932879.001]
  • [Cites] Ai Zheng. 2008 Feb;27(2):196-200 [18279621.001]
  • [Cites] Clin Imaging. 2008 Mar-Apr;32(2):128-35 [18313577.001]
  • [Cites] J Vasc Interv Radiol. 2008 Jun;19(6):931-6 [18503910.001]
  • [Cites] Comp Med. 2008 Jun;58(3):287-93 [18589872.001]
  • [Cites] Invest Radiol. 2008 Aug;43(8):587-93 [18648259.001]
  • [Cites] Surgeon. 2008 Aug;6(4):222-31 [18697365.001]
  • [Cites] Cancer Biol Ther. 2008 May;7(5):721-5 [18285706.001]
  • [Cites] AJR Am J Roentgenol. 2008 Nov;191(5):1517-22 [18941094.001]
  • [Cites] Eur J Surg Oncol. 2009 Feb;35(2):168-73 [18359603.001]
  • [Cites] Semin Ultrasound CT MR. 2008 Dec;29(6):433-53 [19166041.001]
  • [Cites] Colorectal Dis. 2009 Mar;11(3):259-63 [18513197.001]
  • [Cites] Radiology. 2004 Aug;232(2):335-46 [15286305.001]
  • [Cites] Lab Invest. 2004 Dec;84(12):1619-30 [15502862.001]
  • [Cites] Ann Oncol. 2005;16 Suppl 1:i16-7 [15888737.001]
  • [Cites] Eur Radiol. 2003 Jun;13(6):1324-32 [12764649.001]
  • (PMID = 19418587.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2678585
  •  go-up   go-down


45. Read TE: Treatment of rectal cancer without radiotherapy? Dis Colon Rectum; 2006 Jan;49(1):143; author reply 143-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of rectal cancer without radiotherapy?
  • [MeSH-major] Adenocarcinoma / surgery. Colectomy / methods. Colorectal Neoplasms / surgery
  • [MeSH-minor] Humans. Neoplasm Staging. Radiotherapy / contraindications. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Dis Colon Rectum. 2005 Feb;48(2):218-26 [15711860.001]
  • (PMID = 16270164.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comment; Comparative Study; Letter
  • [Publication-country] United States
  •  go-up   go-down


46. Vinikoor LC, Satia JA, Schroeder JC, Millikan RC, Martin CF, Ibrahim JG, Sandler RS: Associations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study I. Nutr Cancer; 2009;61(4):427-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Associations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study I.
  • Disparities in incidence and mortality rates of colon cancer exist between Whites and African Americans.
  • Prior studies examined the association between trans fatty acid consumption and colorectal cancer, but none assessed this possible relationship within a large study population of African Americans and Whites.
  • Energy-adjusted trans fatty acid consumption was not associated with colon cancer.
  • In conclusion, trans fatty acid consumption is not associated with colon cancer and does not contribute to disparities in colon cancer rates.

  • MedlinePlus Health Information. consumer health - African American Health.
  • MedlinePlus Health Information. consumer health - Dietary Fats.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Epidemiol. 1986 Jul;124(1):17-27 [3521261.001]
  • [Cites] Am J Epidemiol. 1985 Nov;122(5):794-804 [3876763.001]
  • [Cites] Cancer Res. 1988 Feb 1;48(3):751-6 [3335035.001]
  • [Cites] Am J Epidemiol. 1991 Aug 15;134(4):421-32 [1877602.001]
  • [Cites] Cancer Res. 1996 May 15;56(10):2314-20 [8625306.001]
  • [Cites] Cancer Causes Control. 1997 Mar;8(2):215-28 [9134246.001]
  • [Cites] Am J Clin Nutr. 1997 Dec;66(6 Suppl):1564S-1571S [9394716.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):519-24 [10385142.001]
  • [Cites] Am J Epidemiol. 2004 Nov 15;160(10):1011-22 [15522858.001]
  • [Cites] Eur J Endocrinol. 2005 Jul;153(1):159-65 [15998628.001]
  • [Cites] Rev Esp Enferm Dig. 2005 Jun;97(6):432-48 [16011418.001]
  • [Cites] JAMA. 2006 Jan 25;295(4):403-15 [16434631.001]
  • [Cites] Atheroscler Suppl. 2006 May;7(2):37-9 [16713388.001]
  • [Cites] Nutr Rev. 2006 Aug;64(8):364-72 [16958313.001]
  • [Cites] Nutr Clin Pract. 2006 Oct;21(5):505-12 [16998148.001]
  • [Cites] Am J Clin Nutr. 2006 Nov;84(5):981-8 [17093147.001]
  • [Cites] CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 [17237035.001]
  • [Cites] Am J Epidemiol. 2007 Jul 15;166(2):181-95 [17493949.001]
  • [Cites] Curr Opin Gastroenterol. 2008 Jan;24(1):51-8 [18043233.001]
  • [Cites] Am J Epidemiol. 2008 Aug 1;168(3):289-97 [18587137.001]
  • [Cites] Dis Colon Rectum. 1997 Apr;40(4):483-93 [9106701.001]
  • [Cites] Annu Rev Med. 2000;51:511-23 [10774479.001]
  • [Cites] Epidemiology. 2000 Jul;11(4):469-73 [10874557.001]
  • [Cites] Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504 [10993420.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1271-9 [11142411.001]
  • [Cites] Ann Epidemiol. 2001 Feb;11(2):145-53 [11164131.001]
  • [Cites] J Nutr. 2001 Nov;131(11 Suppl):3109S-20S [11694656.001]
  • [Cites] Nutr Cancer. 2001;39(2):170-5 [11759276.001]
  • [Cites] Int J Epidemiol. 2003 Apr;32(2):200-9 [12714537.001]
  • [Cites] Br J Nutr. 2003 May;89(5):631-9 [12720583.001]
  • [Cites] Am J Epidemiol. 2003 Nov 15;158(10):951-62 [14607803.001]
  • [Cites] Int J Cancer. 2004 May 1;109(5):728-36 [14999782.001]
  • [Cites] Am J Clin Nutr. 2004 Apr;79(4):606-12 [15051604.001]
  • [Cites] Am J Epidemiol. 1986 Sep;124(3):453-69 [3740045.001]
  • (PMID = 19838914.001).
  • [ISSN] 1532-7914
  • [Journal-full-title] Nutrition and cancer
  • [ISO-abbreviation] Nutr Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01CA66635; United States / NIDDK NIH HHS / DK / P30 DK034987; United States / NIDDK NIH HHS / DK / DK034987-25; United States / NCI NIH HHS / CA / R01 CA066635; United States / NIDDK NIH HHS / DK / T32 DK007634-20; United States / NIDDK NIH HHS / DK / DK56350; United States / NIDDK NIH HHS / DK / DK007634-20; United States / NIDDK NIH HHS / DK / P30 DK056350; United States / NCI NIH HHS / CA / R01 CA066635-09; United States / NIDDK NIH HHS / DK / P30DK34987; United States / NIDDK NIH HHS / DK / T32 DK007634; United States / NIDDK NIH HHS / DK / T32DK07634; United States / NIDDK NIH HHS / DK / P30 DK034987-25
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dietary Fats; 0 / Trans Fatty Acids
  • [Other-IDs] NLM/ NIHMS190542; NLM/ PMC2853475
  •  go-up   go-down


47. Sakellaridis T, Mathioulakis S, Antiochos C: Synchronous early primary adenocarcinoma of both rectum and gallbladder. Report of a case. Int Semin Surg Oncol; 2005 Sep 14;2:19
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous early primary adenocarcinoma of both rectum and gallbladder. Report of a case.
  • BACKGROUND: Synchronous early primary cancers are rare and in addition synchronous adenocarcinoma of both rectum and gallbladder is extremely rare.
  • CASE REPORT: We report an unusual case of synchronous early primary adenocarcinoma of rectum and gallbladder.
  • An endoscopy revealed adenocarcinoma of the lower rectum.
  • The histopathological diagnosis was well to middle differentiate adenocarcinoma of the gallbladder (T2, N0, M0; stage II) and middle differentiate adenocarcinoma of the rectum (T2, N0, M0; stage II).
  • CONCLUSION: For the cases of extracolonic primary cancer associated with colorectal primary carcinoma, Warren and Gates' diagnostic criteria are used.
  • All patients with colorectal carcinoma, should undergo a throughout preoperative examination to exclude the possibility of synchronous early primary cancers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chir Ital. 2001 Jan-Feb;53(1):133-9 [11280822.001]
  • [Cites] Asian J Surg. 2003 Jan;26(1):46-8; discussion 49 [12527496.001]
  • [Cites] Jpn J Cancer Res. 1987 Mar;78(3):242-50 [3106280.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 1997 Jun;94(6):440-4 [9216227.001]
  • [Cites] Gan No Rinsho. 1985 Nov;31(14):1849-53 [4087393.001]
  • [Cites] Srp Arh Celok Lek. 1965 Mar;93(3):323-7 [5861499.001]
  • [Cites] Ann Surg. 1982 Apr;195(4):501-7 [7065754.001]
  • [Cites] Klin Wochenschr. 1988 Nov 1;66(21):1093-6 [3236758.001]
  • (PMID = 16162293.001).
  • [ISSN] 1477-7800
  • [Journal-full-title] International seminars in surgical oncology : ISSO
  • [ISO-abbreviation] Int Semin Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1236954
  •  go-up   go-down


48. Ozmen V, Asoglu O, Karanlik H, Cabioglu N, Kecer M, Bakkaloglu H: Primary ovarian cancer presenting with axillary lymph node metastases: a report of two cases. Acta Chir Belg; 2007 Jan-Feb;107(1):75-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary ovarian cancer presenting with axillary lymph node metastases: a report of two cases.
  • BACKGROUND: Axillary lymph node metastasis of primary ovarian cancer is rare.
  • She had a history of stage IIIA epithelial ovarian cancer which was diagnosed and treated four years previously.
  • A right lateral wall involvement of the rectum was detected in abdominal tomography.
  • A right axillary lymph node dissection and low anterior resection of the rectum were performed.
  • Histopathologic examination showed ovarian epithelial serous papillary adenocarcinoma metastases to axillary lymph node and the rectum.
  • She was treated surgically and by systemic chemotherapy with a diagnosis of stage IIIA epithelial ovarian cancer two years previously.
  • A trucut biopsy was taken from the enlarged axillary lymph node, and histopathological examination revealed metastases of primary ovarian cancer.
  • Complete axillary lymph node dissection was performed and metastases of ovarian papillary adenocarcinoma were found in 11 of the 30 lymph nodes.
  • CONCLUSION: Supradiaphragmatic lymph node involvement of primary ovarian cancer is very rare.
  • We report here two cases presenting with axillary metastases of ovarian cancer.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Lymphatic Metastasis. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Axilla. Female. Humans. Lymph Node Excision. Rectal Neoplasms / pathology. Rectal Neoplasms / secondary

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17405606.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


49. Seo T, Tatsuguchi A, Shinji S, Yonezawa M, Mitsui K, Tanaka S, Fujimori S, Gudis K, Fukuda Y, Sakamoto C: Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients. Virchows Arch; 2009 Jun;454(6):667-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microsomal prostaglandin E synthase protein levels correlate with prognosis in colorectal cancer patients.
  • The aim of this study is to investigate the expression of three prostaglandin E synthase (PGES) isomers in colorectal cancer (CRC) tissue and to evaluate their relationship to clinicopathological factors and patient prognosis.
  • The localization of each PGES and COX-2 protein was examined by immunohistochemistry in 155 surgical resections and correlated to clinicopathological factors and patient prognosis. mPGES-1 mRNA and protein levels were significantly higher in CRC than in paired normal tissues. mPGES-1 immunoreactivity localized in cancer cells in 43% of cases. mPGES-2 immunoreactivity was significantly more pronounced in cancer cells than in adjacent normal epithelium in 36% of cases. cPGES immunoreactivity was homogeneous in cancer cells and thus determined constitutive. mPGES-1 and mPGES-2 correlated with significantly worse prognosis in stage I-III patients.
  • [MeSH-major] Adenocarcinoma / enzymology. Colorectal Neoplasms / enzymology. Intramolecular Oxidoreductases / metabolism. Microsomes / enzymology

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2005 Mar 17;352(11):1092-102 [15713943.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16355-64 [11847219.001]
  • [Cites] Mol Carcinog. 2006 Jun;45(6):447-54 [16688727.001]
  • [Cites] J Biochem Mol Biol. 2005 Nov 30;38(6):633-8 [16336776.001]
  • [Cites] Cancer Res. 1998 Feb 1;58(3):409-12 [9458081.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Mar 8;291(4):884-9 [11866447.001]
  • [Cites] J Biol Chem. 2003 Sep 26;278(39):37937-47 [12835322.001]
  • [Cites] J Immunol. 2001 Jul 1;167(1):469-74 [11418684.001]
  • [Cites] Gut. 2006 Jan;55(1):54-61 [16085694.001]
  • [Cites] Gut. 2006 Jan;55(1):115-22 [16118353.001]
  • [Cites] N Engl J Med. 2006 Aug 31;355(9):885-95 [16943401.001]
  • [Cites] N Engl J Med. 2007 May 24;356(21):2131-42 [17522398.001]
  • [Cites] J Biol Chem. 2000 Oct 20;275(42):32783-92 [10869354.001]
  • [Cites] Br J Pharmacol. 2004 Apr;141(7):1091-7 [15023855.001]
  • [Cites] N Engl J Med. 2006 Aug 31;355(9):873-84 [16943400.001]
  • [Cites] Nat Rev Cancer. 2006 Feb;6(2):130-40 [16491072.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7220-5 [10377395.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Jul 18;372(1):249-53 [18485889.001]
  • [Cites] Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):63-75 [15000150.001]
  • [Cites] Hum Pathol. 2007 Dec;38(12 ):1826-35 [17868774.001]
  • [Cites] Clin Cancer Res. 2005 Jul 1;11(13):4754-60 [16000571.001]
  • [Cites] J Biol Chem. 2000 Oct 20;275(42):32775-82 [10922363.001]
  • [Cites] Dis Colon Rectum. 2006 Aug;49(8):1184-92 [16752205.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Jun 27;306(2):577-81 [12804604.001]
  • [Cites] Cell. 1998 May 29;93(5):705-16 [9630216.001]
  • [Cites] Lab Invest. 2005 Feb;85(2):225-36 [15531909.001]
  • [Cites] Int J Cancer. 2003 Nov 20;107(4):551-6 [14520691.001]
  • [Cites] Cancer Res. 2008 May 1;68(9):3251-9 [18451151.001]
  • [Cites] J Biol Chem. 2003 May 23;278(21):19396-405 [12626523.001]
  • [Cites] Gastroenterology. 2003 Aug;125(2):404-12 [12891542.001]
  • [Cites] J Pathol. 2006 Feb;208(3):356-63 [16353170.001]
  • [Cites] Clin Cancer Res. 2001 Dec;7(12 ):3971-6 [11751489.001]
  • [Cites] J Clin Invest. 2006 May;116(5):1391-9 [16614756.001]
  • [Cites] J Biol Chem. 2002 Aug 16;277(33):30253-63 [12050152.001]
  • [Cites] Mol Cancer. 2006 Nov 16;5:62 [17107625.001]
  • [Cites] Hum Pathol. 2004 Apr;35(4):488-95 [15116331.001]
  • (PMID = 19412621.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Isoenzymes; 0 / RNA, Messenger; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / PTGS2 protein, human; EC 5.3.- / Intramolecular Oxidoreductases; EC 5.3.99.3 / PTGES protein, human; EC 5.3.99.3 / PTGES2 protein, human; EC 5.3.99.3 / Prostaglandin-E Synthases
  •  go-up   go-down


50. Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I: Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials; 2010 May 25;11:62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Peritoneal carcinomatosis from colorectal cancer treated with chemotherapy alone results in median survival of 5 to 13 months, whereas CRS with HIPEC for early peritoneal carcinomatosis from colorectal cancer resulted in median survival of 48-63 months and 5 year survival of 51%.Completeness of cytoreduction and limited disease are associated with longer survival, yet early peritoneal carcinomatosis is undetectable by conventional imaging.
  • We hypothesize that performing a mandatory second look laparotomy with CRS and HIPEC for patients who are at high risk for developing peritoneal carcinomatosis from colorectal cancer will lead to improved survival as compared to patients who receive standard of care with routine surveillance.
  • METHODS/DESIGN: This study is a prospective randomized trial designed to answer the question whether mandatory second look surgery with CRS and HIPEC will prolong overall survival compared to the standard of care in patients who are at high risk for developing peritoneal carcinomatosis from colorectal cancer (CRC).
  • [MeSH-major] Adenocarcinoma / therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Cancer, Regional Perfusion. Colorectal Neoplasms / therapy. Hyperthermia, Induced. Laparotomy. Peritoneal Neoplasms / therapy. Second-Look Surgery

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Oncol. 2002 Feb;13(2):267-72 [11886004.001]
  • [Cites] Oncology. 2002;63(4):346-52 [12417789.001]
  • [Cites] Br J Surg. 2002 Dec;89(12):1545-50 [12445064.001]
  • [Cites] J Clin Oncol. 2003 Jun 1;21(11):2059-69 [12775730.001]
  • [Cites] J Clin Oncol. 2003 Oct 15;21(20):3737-43 [14551293.001]
  • [Cites] J Clin Oncol. 2003 Dec 15;21(24):4560-7 [14673042.001]
  • [Cites] Ann Oncol. 2004 May;15(5):781-5 [15111347.001]
  • [Cites] N Engl J Med. 2004 Jun 3;350(23):2335-42 [15175435.001]
  • [Cites] J Clin Oncol. 2004 Aug 15;22(16):3284-92 [15310771.001]
  • [Cites] Dis Colon Rectum. 1984 Dec;27(12):792-7 [6389051.001]
  • [Cites] J Clin Oncol. 1985 Mar;3(3):379-84 [3973649.001]
  • [Cites] Langenbecks Arch Chir. 1988;373(3):189-96 [3288830.001]
  • [Cites] Cancer. 1989 Jan 15;63(2):364-7 [2910444.001]
  • [Cites] Cancer Res. 1990 Sep 15;50(18):5790-4 [2118420.001]
  • [Cites] Ann Surg. 1990 Nov;212(5):592-6 [2241314.001]
  • [Cites] Hepatogastroenterology. 1994 Jun;41(3):207-13 [7959539.001]
  • [Cites] Ann Surg. 1995 Jan;221(1):29-42 [7826158.001]
  • [Cites] J Cancer Res Clin Oncol. 1997;123(1):6-12 [8996534.001]
  • [Cites] J Clin Oncol. 1998 Aug;16(8):2739-44 [9704726.001]
  • [Cites] Ann Surg Oncol. 2005 Jan;12(1):65-71 [15827780.001]
  • [Cites] J Clin Oncol. 2005 May 20;23(15):3502-8 [15908660.001]
  • [Cites] J Clin Oncol. 2005 Aug 1;23(22):4866-75 [15939922.001]
  • [Cites] Lancet Oncol. 2006 Jan;7(1):69-76 [16389186.001]
  • [Cites] N Engl J Med. 2006 Jan 5;354(1):34-43 [16394300.001]
  • [Cites] J Clin Oncol. 2006 Aug 20;24(24):4011-9 [16921055.001]
  • [Cites] Gastroenterol Clin Biol. 2006 Oct;30(10):1200-4 [17075479.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Ann Surg. 2008 Mar;247(3):445-50 [18376188.001]
  • [Cites] J Surg Oncol. 2008 Sep 15;98(4):224-7 [18726881.001]
  • [Cites] J Clin Oncol. 2009 Feb 10;27(5):681-5 [19103728.001]
  • [Cites] Cancer J. 2009 May-Jun;15(3):243-8 [19556911.001]
  • [Cites] J Clin Oncol. 2000 Jan;18(1):136-47 [10623704.001]
  • [Cites] Cancer. 2000 Jan 15;88(2):358-63 [10640968.001]
  • [Cites] Lancet. 2000 Mar 25;355(9209):1041-7 [10744089.001]
  • [Cites] J Clin Oncol. 2000 Aug;18(16):2938-47 [10944126.001]
  • [Cites] Int J Surg Investig. 2000;1(5):431-9 [11341599.001]
  • (PMID = 20500867.001).
  • [ISSN] 1745-6215
  • [Journal-full-title] Trials
  • [ISO-abbreviation] Trials
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT01095523
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  • [Other-IDs] NLM/ PMC2889988
  •  go-up   go-down


51. Chan AC, Poon JT, Fan JK, Lo SH, Law WL: Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer. Surg Endosc; 2008 Dec;22(12):2625-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of conversion on the long-term outcome in laparoscopic resection of colorectal cancer.
  • BACKGROUND: Long-term outcome of patients with conversion following laparoscopic resection of colorectal cancer has seldom been reported.
  • Consequently, patients in the conversion group were more likely to develop local recurrence (9.8% versus 2.8%, P < 0.001) with a significantly reduced cumulative cancer-free survival.
  • [MeSH-major] Adenocarcinoma / surgery. Colectomy / methods. Colorectal Neoplasms / surgery. Laparoscopy / statistics & numerical data. Laparotomy / statistics & numerical data
  • [MeSH-minor] Aged. Blood Loss, Surgical / statistics & numerical data. Disease-Free Survival. Female. Humans. Kaplan-Meier Estimate. Length of Stay / statistics & numerical data. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Prospective Studies. Survival Analysis. Treatment Outcome. Tumor Burden

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet Oncol. 2005 Jul;6(7):477-84 [15992696.001]
  • [Cites] Arch Surg. 2004 Jan;139(1):39-42 [14718273.001]
  • [Cites] Arch Surg. 1997 Jan;132(1):41-4; discussion 45 [9006551.001]
  • [Cites] Surg Endosc. 2001 Aug;15(8):827-32 [11443444.001]
  • [Cites] Ann Surg. 2005 Jul;242(1):83-91 [15973105.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1718-26 [15894098.001]
  • [Cites] Dis Colon Rectum. 2003 Apr;46(4):503-9 [12682545.001]
  • [Cites] Surg Endosc. 2004 May;18(5):732-5 [15216851.001]
  • [Cites] Dis Colon Rectum. 2001 Feb;44(2):207-14; discussion 214-6 [11227937.001]
  • [Cites] Dis Colon Rectum. 2004 Oct;47(10):1680-5 [15540299.001]
  • [Cites] Surg Endosc. 2000 Dec;14(12):1114-7 [11148778.001]
  • [Cites] J Am Coll Surg. 2004 Nov;199(5):675-9 [15501105.001]
  • [Cites] Dis Colon Rectum. 2006 Feb;49(2):197-204 [16328607.001]
  • [Cites] Surg Endosc. 2005 Jan;19(1):47-54 [15549630.001]
  • [Cites] Surg Endosc. 1997 Apr;11(4):331-5 [9094271.001]
  • [Cites] Surg Endosc. 2006 Jun;20(6):947-51 [16738988.001]
  • (PMID = 18297346.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


52. Vijayasekar C, Noormohamed S, Cheetham MJ: Late recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer. World J Surg Oncol; 2008;6:96
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late recurrence of large peri-stomal metastasis following abdomino-perineal resection of rectal cancer.
  • BACKGROUND: Cutaneous metastasis from colorectal cancer after excision of the primary is a rare occurrence and presents as cutaneous or subcutaneous nodules or as a rash commonly on the anterior abdominal wall.
  • CASE PRESENTATION: This is a case description of the management of a large fungating peristomal cutaneous metastasis occurring 14 years after abdomino-perineal excision of the primary cancer.
  • The gross appearance initially suggested possibility of a true metachronous cancer with peristomal spread.
  • Literature review of presentation, management and prognosis of cutaneous metastasis from colorectal cancer is described CONCLUSION: Cutaneous metastasis following colorectal cancer resection is a well-recognised entity though rare.
  • [MeSH-major] Adenocarcinoma / surgery. Colostomy. Neoplasm Recurrence, Local / surgery. Rectal Neoplasms / surgery. Skin Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):161-82; quiz 183-6 [7622642.001]
  • [Cites] J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):228-36 [8335743.001]
  • [Cites] Tech Coloproctol. 2004 Nov;8 Suppl 1:s101-3 [15655588.001]
  • [Cites] J Clin Oncol. 2005 Aug 1;23(22):4856-65 [15939923.001]
  • [Cites] Dermatol Online J. 2005;11(2):22 [16150230.001]
  • [Cites] J Surg Oncol. 2005 Nov 1;92(2):124-9 [16231370.001]
  • [Cites] Ann R Coll Surg Engl. 2005 Nov;87(6):e1-3 [16263022.001]
  • [Cites] Ann Acad Med Singapore. 2006 Aug;35(8):585-7 [17006588.001]
  • [Cites] Arch Dermatol. 2006 Oct;142(10):1372-3 [17043208.001]
  • [Cites] World J Surg Oncol. 2007;5:52 [17567928.001]
  • [Cites] Dis Colon Rectum. 2000 May;43(5):628-32 [10826422.001]
  • [Cites] N Engl J Med. 2000 Sep 28;343(13):905-14 [11006366.001]
  • [Cites] Eur J Surg Oncol. 2000 Aug;26(5):518-9 [11016477.001]
  • [Cites] Chir Ital. 2001 May-Jun;53(3):405-7 [11452828.001]
  • [Cites] J Gastroenterol. 2002;37(5):387-90 [12051539.001]
  • [Cites] Tech Coloproctol. 2003 Jul;7(2):105-7 [14605930.001]
  • [Cites] J Clin Oncol. 2004 Jan 1;22(1):23-30 [14665611.001]
  • [Cites] J Clin Oncol. 2004 Jan 15;22(2):229-37 [14657227.001]
  • [Cites] J Cutan Pathol. 2004 Jul;31(6):419-30 [15186430.001]
  • [Cites] Int J Clin Oncol. 2004 Jun;9(3):202-5 [15221607.001]
  • [Cites] Tumori. 2004 Mar-Apr;90(2):253-5 [15237593.001]
  • [Cites] Dis Colon Rectum. 1983 Sep;26(9):571-2 [6223795.001]
  • [Cites] Dis Colon Rectum. 1996 Feb;39(2):200-7 [8620788.001]
  • (PMID = 18771600.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2542374
  •  go-up   go-down


53. Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J: Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis. BMC Health Serv Res; 2009;9:227
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis.
  • BACKGROUND: Analyses of utilization trends (cost drivers) allow us to understand changes in colorectal cancer (CRC) costs over time, better predict future costs, identify changes in the use of specific types of care (eg, hospice), and provide inputs for cost-effectiveness models.
  • METHODS: Cohorts included patients aged 66+ newly diagnosed with adenocarcinoma of the colon (n = 52,371) or rectum (n = 18,619) between 1992 and 2002 and matched patients from the general Medicare population, followed until death or December 31, 2005.
  • Demographic and clinical characteristics were evaluated by cancer subsite.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Public Health. 2000 May;90(5):695-8 [10800415.001]
  • [Cites] Clin Gastroenterol Hepatol. 2009 Feb;7(2):198-204 [18849013.001]
  • [Cites] Med Care. 2002 Aug;40(8 Suppl):IV-104-17 [12187175.001]
  • [Cites] J Clin Oncol. 2003 Feb 15;21(4):728-35 [12586813.001]
  • [Cites] JAMA. 2003 May 7;289(17):2238-45 [12734135.001]
  • [Cites] Am J Med. 2003 Jul;115(1):47-53 [12867234.001]
  • [Cites] J Palliat Med. 2003 Oct;6(5):757-68 [14622455.001]
  • [Cites] J Clin Oncol. 2004 Jan 15;22(2):315-21 [14722041.001]
  • [Cites] Med Care. 2004 Feb;42(2):116-22 [14734948.001]
  • [Cites] Health Serv Res. 2004 Aug;39(4 Pt 1):969-83 [15230937.001]
  • [Cites] J Clin Epidemiol. 1992 Jun;45(6):613-9 [1607900.001]
  • [Cites] Med Care. 1993 Aug;31(8):732-48 [8336512.001]
  • [Cites] Palliat Med. 2005 Mar;19(2):160-2 [15810757.001]
  • [Cites] J Clin Epidemiol. 2005 Apr;58(4):323-37 [15862718.001]
  • [Cites] J Pain Symptom Manage. 2007 Mar;33(3):238-46 [17349493.001]
  • [Cites] J Womens Health (Larchmt). 2007 Mar;16(2):214-27 [17388738.001]
  • [Cites] Int J Cancer. 2007 Aug 15;121(4):871-7 [17417782.001]
  • [Cites] Soc Sci Med. 2007 Oct;65(7):1466-78 [17600605.001]
  • [Cites] Health Econ. 2008 Aug;17(8):947-59 [17910108.001]
  • [Cites] Med Care. 2002 Aug;40(8 Suppl):IV-3-18 [12187163.001]
  • (PMID = 20003294.001).
  • [ISSN] 1472-6963
  • [Journal-full-title] BMC health services research
  • [ISO-abbreviation] BMC Health Serv Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2797788
  •  go-up   go-down


54. Papatheodorou A, Ellinas P, Tandeles S, Takis F, Poulias H, Nikolaou I, Batakis N: Transrectal ultrasonography and ultrasound-guided biopsies of the prostate gland: how, when, and where. Curr Probl Diagn Radiol; 2005 Mar-Apr;34(2):76-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Aged, 80 and over. Contrast Media. Humans. Male. Microbubbles. Middle Aged. Prostatic Hyperplasia / pathology. Rectum

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15753881.001).
  • [ISSN] 0363-0188
  • [Journal-full-title] Current problems in diagnostic radiology
  • [ISO-abbreviation] Curr Probl Diagn Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


55. Jabbari S, Hsu IC, Kawakami J, Weinberg VK, Speight JL, Gottschalk AR, Roach M 3rd, Shinohara K: High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. Brachytherapy; 2009 Oct-Dec;8(4):339-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
  • PURPOSE: Treatment options are limited for patients with localized prostate cancer and a prior history of abdominoperineal resection (APR) and pelvic irradiation.
  • We have previously reported on the successful utility of high-dose-rate (HDR) brachytherapy salvage for prostate cancer failing definitive external beam radiation therapy (EBRT).
  • PATIENTS AND METHODS: Six men with newly diagnosed localized prostate cancer had a prior history of APR and pelvic EBRT.
  • CONCLUSION: Transperineal ultrasound-guided HDR brachytherapy using the above technique should be considered as definitive therapy for patients with localized prostate cancer and a prior history of APR and pelvic EBRT.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Brachytherapy / methods. Prostatic Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19428310.001).
  • [ISSN] 1538-4721
  • [Journal-full-title] Brachytherapy
  • [ISO-abbreviation] Brachytherapy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T: Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. Eur J Surg Oncol; 2007 Mar;33(2):183-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
  • BACKGROUND: Carcinoembryonic antigen (CEA) as a marker in the follow-up after curative resection of colorectal carcinoma (CRC) is often omitted from follow-up despite guideline recommendations.
  • METHOD: Data were derived from a study initiated to evaluate treatment regimes for rectal carcinoma (Dutch TME trial, n=1861) from which 954 were eligible for analysis.
  • CONCLUSION: A normal pre-operative CEA is common in patients with rectal carcinoma.
  • [MeSH-major] Biomarkers, Tumor / blood. Carcinoembryonic Antigen / blood. Colectomy / methods. Preoperative Care. Rectal Neoplasms / blood
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Clinical Trials as Topic. Disease Progression. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / blood. Neoplasm Recurrence, Local / epidemiology. Netherlands / epidemiology. Prognosis. Retrospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17174516.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen
  •  go-up   go-down


57. Tsunoda A, Kamiyama G, Narita K, Watanabe M, Nakao K, Kusano M: Prospective randomized trial for determination of optimum size of side limb in low anterior resection with side-to-end anastomosis for rectal carcinoma. Dis Colon Rectum; 2009 Sep;52(9):1572-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prospective randomized trial for determination of optimum size of side limb in low anterior resection with side-to-end anastomosis for rectal carcinoma.
  • METHODS: Forty-four patients with a mid or low rectal cancer undergoing low anterior resection were randomly assigned to each group.
  • [MeSH-major] Carcinoma / surgery. Proctocolectomy, Restorative / methods. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19690484.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


58. Onodera M, Nishigami T, Torii I, Sato A, Tao LH, Kataoka TR, Yoshikawa R, Tsujimura T: Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC. World J Gastrointest Oncol; 2009 Oct 15;1(1):69-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC.
  • AIM: To explore useful prognostic factors for mucinous adenocarcinoma (MAC) in the colon and rectum.
  • METHODS: MAC was divided into low- and high-grade types based on the degree of structural differentiation; low-grade MAC arisen from well to moderately differentiated adenocarcinoma and papillary carcinoma, and high-grade MAC from poorly differentiated adenocarcinoma and signet ring cell carcinoma.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160777.001).
  • [ISSN] 1948-5204
  • [Journal-full-title] World journal of gastrointestinal oncology
  • [ISO-abbreviation] World J Gastrointest Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2999097
  • [Keywords] NOTNLM ; Colon / MUC1 / MUC5AC / Mucinous adenocarcinoma / Rectum
  •  go-up   go-down


59. Cimitan A, Burza A, Basile U, Saputo S, Mingazzini P, Stipa F: [Local excision of giant rectal polypoid neoplasms]. Chir Ital; 2008 May-Jun;60(3):345-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Local excision of giant rectal polypoid neoplasms].
  • [Transliterated title] Escissione locale delle neoplasie polipoidi giganti del retto.
  • Local excision is the best therapeutic option for giant adenomas of the rectum.
  • Parks technique for lower rectal lesions and the T.E.M. technique for lesions localised in the middle and upper rectum offer exceptionally good exposure, allowing radical excision in the case of early low-risk T1 adenocarcinomas (well or moderately differentiated [G1/2] without lymphovascular invasion [L0]).
  • From July 1987 to March 2006, 224 patients were treated by local excision for rectal lesions in our department.
  • In 3 patients with a preoperative diagnosis of severe dysplasia (Tis) final pathology showed adenoma and for this reason they were included in our study group.
  • Twenty-five (49%) patients had a definitive diagnosis of adenocarcinoma: in situ (pTis) in 22 patients (88%), pT1 in 2 patients (8%) and pT2 in 1 patient (4%).
  • In 26 patients (51%) the diagnosis was adenoma.
  • Giant sessile polypoid lesions localized in the middle and upper rectum are best treated with T.E.M., while Parks technique is a good option in lower rectal tumours.
  • [MeSH-major] Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18709772.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


60. Slosar M, Vohra P, Prasad M, Fischer A, Quinlan R, Khan A: Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors. Endocr Pathol; 2009;20(3):149-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.
  • It is highly expressed in carcinomas of the pancreas, stomach, colon, rectum, kidneys, uterine cervix, lung, and ovary.
  • We immunostained 219 thyroid lesions selected from our surgical pathology archives including 14 hyperplastic colloid nodules (CN), 19 Hashimoto's thyroiditis (HT), two Graves disease (GD), ten Hürthle cell adenoma (HCA), 20 follicular adenoma (FA), 37 conventional papillary thyroid carcinoma (PTC), 60 follicular variant of papillary carcinoma (FVPC), 19 Hürthle cell carcinoma (HCC), 32 follicular carcinoma (FC), and six poorly differentiated/anaplastic carcinoma.
  • No significant correlation was found between pathologic tumor characteristics and IMP3 expression in differentiated follicular pattern thyroid carcinoma.
  • With 100% specificity and 69% sensitivity for FC as compared to FA and 100% specificity for FVPC, again compared to FA, IMP3 has the potential to be diagnostically useful in differentiating malignant and benign follicular pattern thyroid lesions.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Biomarkers, Tumor / analysis. Neoplasm Proteins / biosynthesis. RNA-Binding Proteins / biosynthesis. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mod Pathol. 1994 Apr;7(3):295-300 [7520169.001]
  • [Cites] J Pathol. 2005 Jul;206(3):305-11 [15852498.001]
  • [Cites] Thyroid. 2001 Dec;11(12):1101-7 [12186496.001]
  • [Cites] Endocr Relat Cancer. 2005 Jun;12(2):305-17 [15947105.001]
  • [Cites] Am J Clin Pathol. 2003 Jul;120(1):71-7 [12866375.001]
  • [Cites] Am J Surg Pathol. 2008 Feb;32(2):304-15 [18223334.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):338-42 [11301350.001]
  • [Cites] Hum Pathol. 1998 Nov;29(11):1304-9 [9824112.001]
  • [Cites] Cancer. 2008 Feb 25;114(1):49-56 [18098206.001]
  • [Cites] World J Surg. 2000 Aug;24(8):913-22 [10865035.001]
  • [Cites] Lancet. 2001 May 26;357(9269):1644-50 [11425367.001]
  • [Cites] Hum Pathol. 2007 Aug;38(8):1178-83 [17521698.001]
  • [Cites] Pathology. 2005 Aug;37(4):296-8 [16194828.001]
  • [Cites] Mod Pathol. 2007 Feb;20(2):242-7 [17192788.001]
  • [Cites] Am J Clin Pathol. 2002 Jan;117(1):143-50 [11789719.001]
  • [Cites] Lancet Oncol. 2006 Jul;7(7):556-64 [16814207.001]
  • [Cites] Br J Cancer. 2003 Mar 24;88(6):887-94 [12644826.001]
  • [Cites] Oncogene. 1997 Jun 5;14(22):2729-33 [9178771.001]
  • [Cites] Mech Dev. 1999 Oct;88(1):95-9 [10525192.001]
  • [Cites] Int J Surg Pathol. 2005 Jul;13(3):235-8 [16086077.001]
  • [Cites] Am J Clin Pathol. 2001 Nov;116(5):696-702 [11710686.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):256-64 [16082252.001]
  • [Cites] Exp Oncol. 2006 Mar;28(1):70-4 [16614712.001]
  • [Cites] Mod Pathol. 2000 Aug;13(8):882-7 [10955455.001]
  • [Cites] Am J Clin Pathol. 2006 Nov;126(5):700-8 [17050067.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Jan;91(1):213-20 [16219715.001]
  • [Cites] Mod Pathol. 1995 Oct;8(8):870-2 [8552578.001]
  • [Cites] Acta Cytol. 2008 Mar-Apr;52(2):133-8 [18499984.001]
  • [Cites] Virchows Arch. 1998 May;432(5):427-32 [9645441.001]
  • [Cites] Cancer. 2008 Jun 15;112(12):2676-82 [18412154.001]
  • [Cites] Histopathology. 2004 Nov;45(5):493-500 [15500653.001]
  • [Cites] Endocr Pathol. 2005 Winter;16(4):295-309 [16627917.001]
  • [Cites] Am J Surg Pathol. 2005 Feb;29(2):188-95 [15644775.001]
  • [Cites] Br J Cancer. 2003 Mar 10;88(5):699-701 [12618877.001]
  • [Cites] Pathol Res Pract. 2000;196(8):533-40 [10982016.001]
  • [Cites] Endocr Pathol. 2006 Summer;17(2):109-17 [17159243.001]
  • [Cites] J Exp Med. 1999 Apr 5;189(7):1101-10 [10190901.001]
  • (PMID = 19449140.001).
  • [ISSN] 1559-0097
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / IMP3 protein, human; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA-Binding Proteins
  •  go-up   go-down


61. Koo VS, Lynn NN, Saxby MF: Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum. J Surg Case Rep; 2010;2010(4):6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum.
  • The management of mucinous prostatic adenocarcinoma include hormonal treatment, radiotherapy and radical prostatectomy with variable long-term outcome.
  • We report a 59 year old man with advanced mucinous prostatic adenocarcinoma involving almost the entire bladder and had failed treatment with hormonal and radiotherapy, but subsequently underwent radical pelvic exenteration surgery that resulted in long-term cure.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © JSCR.
  • (PMID = 24946309.001).
  • [ISSN] 2042-8812
  • [Journal-full-title] Journal of surgical case reports
  • [ISO-abbreviation] J Surg Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3649112
  •  go-up   go-down


62. Oguz M, Bedirli A, Gultekin A, Dursun A, Mentes BB: Desmoid tumor arising at the colostomy site after abdominoperineal resection for rectal carcinoma: report of a case. Dis Colon Rectum; 2006 Sep;49(9):1445-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor arising at the colostomy site after abdominoperineal resection for rectal carcinoma: report of a case.
  • A 69-year-old male who developed a desmoid tumor at the site of his end colostomy after abdominoperineal resection for rectal carcinoma is reported.
  • Histopathology revealed desmoid tumor of the anterior abdominal wall with no malignant features.
  • [MeSH-major] Abdominal Wall. Colostomy. Fibromatosis, Aggressive / pathology. Muscle Neoplasms / pathology. Neoplasms, Second Primary / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Humans. Male. Rectum / surgery

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16897327.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Hsiung PL, Wang T: In vivo biomarkers for targeting colorectal neoplasms. Cancer Biomark; 2008;4(6):329-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colorectal carcinoma continues to be a leading cause of cancer morbidity and mortality despite widespread adoption of screening methods.
  • Targeted detection and therapy using recent advances in our knowledge of in vivo cancer biomarkers promise to significantly improve methods for early detection, risk stratification, and therapeutic intervention.
  • [MeSH-major] Adenocarcinoma / diagnosis. Biomarkers, Tumor / analysis. Colorectal Neoplasms / diagnosis. Molecular Probe Techniques

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 2003 Nov;98(11):2543-9 [14638361.001]
  • [Cites] Nat Med. 2008 Apr;14(4):454-8 [18345013.001]
  • [Cites] J Clin Oncol. 2004 May 1;22(9):1564-71 [15051756.001]
  • [Cites] Clin Cancer Res. 2004 May 1;10(9):3069-75 [15131045.001]
  • [Cites] N Engl J Med. 2004 Jul 22;351(4):337-45 [15269313.001]
  • [Cites] Cancer Res. 2004 Sep 1;64(17):6247-51 [15342411.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Oct;2(10):905-11 [15476154.001]
  • [Cites] Nature. 1987 Aug 27-Sep 2;328(6133):820-3 [3498122.001]
  • [Cites] N Engl J Med. 1988 Sep 1;319(9):525-32 [2841597.001]
  • [Cites] Science. 1992 May 1;256(5057):668-70 [1350108.001]
  • [Cites] Cancer. 1992 Sep 15;70(6 Suppl):1727-31 [1516027.001]
  • [Cites] Cancer Res. 1995 Sep 15;55(18):3964-8 [7664263.001]
  • [Cites] Gastrointest Endosc. 1996 Jul;44(1):15-22 [8836711.001]
  • [Cites] Nature. 1997 Apr 10;386(6625):623-7 [9121588.001]
  • [Cites] Breast Cancer Res Treat. 1997 Aug;45(1):29-37 [9285114.001]
  • [Cites] Nat Biotechnol. 1997 Nov;15(12):1271-5 [9359110.001]
  • [Cites] Q J Nucl Med. 1998 Mar;42(1):33-42 [9646643.001]
  • [Cites] Br J Cancer. 1998 Nov;78(10):1379-84 [9823983.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):123-7 [9916805.001]
  • [Cites] Nat Biotechnol. 1999 Apr;17(4):375-8 [10207887.001]
  • [Cites] Immunol Rev. 1999 Jun;169:195-207 [10450518.001]
  • [Cites] Oncogene. 1999 Sep 20;18(38):5325-33 [10498885.001]
  • [Cites] J Vasc Res. 2004 Sep-Oct;41(5):400-11 [15467299.001]
  • [Cites] Dis Colon Rectum. 2004 Nov;47(11):1904-14 [15622584.001]
  • [Cites] J Clin Oncol. 2005 May 20;23(15):3526-35 [15908663.001]
  • [Cites] Gastroenterology. 2005 Sep;129(3):874-84 [16143127.001]
  • [Cites] Oncogene. 2005 Sep 8;24(40):6155-64 [16091735.001]
  • [Cites] Gastrointest Endosc. 2005 Oct;62(4):521-8 [16185965.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9200-5 [16230380.001]
  • [Cites] Dis Colon Rectum. 2005 Dec;48(12):2238-48 [16228831.001]
  • [Cites] J Mol Diagn. 2006 Feb;8(1):68-75 [16436636.001]
  • [Cites] Am J Gastroenterol. 2006 Feb;101(2):343-50 [16454841.001]
  • [Cites] Ann Surg Oncol. 2006 Jun;13(6):823-35 [16614884.001]
  • [Cites] Ann Surg Oncol. 2006 Aug;13(8):1021-34 [16897272.001]
  • [Cites] Neoplasia. 2006 Sep;8(9):772-80 [16984734.001]
  • [Cites] Gastrointest Endosc. 2006 Oct;64(4):589-97 [16996355.001]
  • [Cites] Cancer. 2006 Oct 1;107(7):1624-33 [16933324.001]
  • [Cites] Cancer Res. 2006 Oct 15;66(20):9804-8 [17047040.001]
  • [Cites] Oncologist. 2007 Apr;12(4):443-50 [17470687.001]
  • [Cites] Dis Colon Rectum. 2007 Jun;50(6):839-55 [17308939.001]
  • [Cites] Radiology. 2007 Jul;244(1):232-8 [17507718.001]
  • [Cites] Cancer Res. 2007 Oct 15;67(20):9721-30 [17942902.001]
  • [Cites] Endoscopy. 1999 Sep;31(7):511-6 [10533733.001]
  • [Cites] J Cell Biochem Suppl. 2000;34:28-34 [10762012.001]
  • [Cites] Am J Gastroenterol. 2000 Apr;95(4):1062-7 [10763960.001]
  • [Cites] Nature. 2000 Apr 27;404(6781):1003-7 [10801130.001]
  • [Cites] Clin Cancer Res. 2000 Jul;6(7):2803-7 [10914727.001]
  • [Cites] Clin Gastroenterol Hepatol. 2007 Nov;5(11):1300-5 [17936692.001]
  • [Cites] N Engl J Med. 2007 Nov 15;357(20):2040-8 [18003960.001]
  • [Cites] Gastroenterology. 2000 Sep;119(3):854-65 [10982779.001]
  • [Cites] Cancer Res. 2000 Sep 1;60(17):4953-8 [10987312.001]
  • [Cites] Nat Med. 2001 Jun;7(6):743-8 [11385514.001]
  • [Cites] Cell. 2002 Jan 25;108(2):135-44 [11832204.001]
  • [Cites] Gastroenterology. 2002 Feb;122(2):406-14 [11832455.001]
  • [Cites] Nat Rev Cancer. 2002 Apr;2(4):251-65 [12001987.001]
  • [Cites] Gastrointest Endosc Clin N Am. 2002 Jul;12(3):495-523 [12486941.001]
  • [Cites] Eur J Cancer. 2003 May;39(8):1041-52 [12736102.001]
  • [Cites] J Cancer Res Clin Oncol. 2003 May;129(5):263-71 [12750996.001]
  • [Cites] Surg Oncol. 2007 Dec;16 Suppl 1:S93-6 [18257148.001]
  • [Cites] Nat Methods. 2008 Mar;5(3):231-3 [18264107.001]
  • [Cites] JAMA. 2008 Mar 5;299(9):1027-35 [18319413.001]
  • [Cites] Clin Ther. 2008 Jan;30(1):14-30 [18343240.001]
  • [Cites] Mol Imaging. 2003 Oct;2(4):350-7 [14717334.001]
  • (PMID = 19126961.001).
  • [ISSN] 1574-0153
  • [Journal-full-title] Cancer biomarkers : section A of Disease markers
  • [ISO-abbreviation] Cancer Biomark
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / K08 DK067618; United States / NIDDK NIH HHS / DK / K08 DK067618-06; United States / NIDDK NIH HHS / DK / R03 DK075603; United States / NIDDK NIH HHS / DK / R03 DK075603-03; United States / NCI NIH HHS / CA / R33 CA109988; United States / NCI NIH HHS / CA / R33 CA109988-05; United States / NCI NIH HHS / CA / U54 CA136429; United States / NCI NIH HHS / CA / U54 CA136429-05
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 68
  • [Other-IDs] NLM/ NIHMS336978; NLM/ PMC3232019
  •  go-up   go-down


64. Bianchi PP, Ceriani C, Locatelli A, Spinoglio G, Zampino MG, Sonzogni A, Crosta C, Andreoni B: Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surg Endosc; 2010 Nov;24(11):2888-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes.
  • BACKGROUND: We assessed feasibility, short-term oncologic safety, and short-term outcomes in robotic total mesorectal excision (R-TME) for rectal cancer compared with laparoscopic TME.
  • METHODS: From March 2008 to June 2009, 50 patients with proven middle/lower rectal adenocarcinoma underwent minimally invasive TME; 25 received R-TME.
  • CONCLUSIONS: R-TME in rectal cancer is feasible, with short-term oncologic and other outcomes similar to those of L-TME.
  • [MeSH-major] Adenocarcinoma / surgery. Laparoscopy. Rectal Neoplasms / surgery. Rectum / surgery. Robotics

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Surg Endosc. 2011 Dec;25(12):3954-6; author reply 3957-8 [21695585.001]
  • [Cites] Lancet Oncol. 2005 Jul;6(7):477-84 [15992696.001]
  • [Cites] Dis Colon Rectum. 2008 Jan;51(1):26-31 [18085339.001]
  • [Cites] N Engl J Med. 2004 May 13;350(20):2050-9 [15141043.001]
  • [Cites] Surg Endosc. 2005 Jul;19(7):892-6 [15920688.001]
  • [Cites] Ann Surg Oncol. 2009 Jun;16(6):1480-7 [19290486.001]
  • [Cites] BJU Int. 2009 Nov;104(10):1428-35 [19804427.001]
  • [Cites] Br J Surg. 2009 Sep;96(9):982-9 [19644973.001]
  • [Cites] J Gastrointest Surg. 2009 Feb;13(2):275-81 [18941844.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005200 [17054246.001]
  • [Cites] Ann Surg Oncol. 2007 Nov;14(11):3168-73 [17763911.001]
  • [Cites] Ann Surg. 2009 Jul;250(1):54-61 [19561481.001]
  • [Cites] Lancet. 2005 May 14-20;365(9472):1718-26 [15894098.001]
  • [Cites] J Surg Oncol. 2007 Dec 15;96(8):660-4 [18081161.001]
  • [Cites] J Clin Oncol. 2007 Jul 20;25(21):3061-8 [17634484.001]
  • [Cites] Singapore Med J. 2009 Aug;50(8):763-7 [19710972.001]
  • [Cites] Ann Surg Oncol. 2009 May;16(5):1274-8 [19242762.001]
  • [Cites] Surg Endosc. 2005 Jun;19(6):757-66 [15868256.001]
  • [Cites] Surg Endosc. 2009 Feb;23(2):447-51 [19057962.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):335-42 [12616116.001]
  • [Cites] Dis Colon Rectum. 2008 Nov;51(11):1627-32 [18484134.001]
  • [Cites] Ann Surg Oncol. 2009 May;16(5):1279-86 [19252948.001]
  • [Cites] Dis Colon Rectum. 2009 Apr;52(4):558-66 [19404053.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Ann Surg Oncol. 2009 Jun;16(6):1488-93 [19290491.001]
  • [Cites] Surg Endosc. 2006 Oct;20(10):1521-5 [16897284.001]
  • [Cites] Dis Colon Rectum. 2007 Dec;50(12):2047-53 [17906896.001]
  • (PMID = 20526623.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


65. Cabassa P, Morone M, Gatti E, Narbone M, Maroldi R: Gardner syndrome complicated with hydronephrosis. A case report. J Radiol Case Rep; 2010;4(3):19-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of a man who was admitted for a relapse of adenocarcinoma of the rectum.
  • CT-staging showed multiple locations of desmoid tumors and osteomas, with final diagnosis of Gardner syndrome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22470715.001).
  • [ISSN] 1943-0922
  • [Journal-full-title] Journal of radiology case reports
  • [ISO-abbreviation] J Radiol Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3303379
  • [Keywords] NOTNLM ; Gardner / computed tomography / desmoid tumors
  •  go-up   go-down


66. Toyooka M, Shoji Y: [A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection]. Gan To Kagaku Ryoho; 2007 Apr;34(4):635-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
  • Computed tomography, barium enema and colonoscopy revealed a cysto-rectal fistula and massive invasion to middle rectum and retroperitoneal space from the main tumor in the upper rectum.
  • Therefore, oral administration of UFT/LV+CPT-11 was considered as effective neoadjuvant chemotherapy for advanced rectal carcinoma, and this also could be a promising regimen to maintain the quality of life (QOL) for patients in ambulatory therapy.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / surgery. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Pelvic Neoplasms / pathology. Rectal Neoplasms / drug therapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Administration, Oral. Aged. Ambulatory Care. Camptothecin / administration & dosage. Camptothecin / analogs & derivatives. Chemotherapy, Adjuvant. Drug Administration Schedule. Drug Combinations. Humans. Leucovorin / administration & dosage. Male. Neoadjuvant Therapy. Neoplasm Invasiveness. Quality of Life. Tegafur / administration & dosage. Uracil / administration & dosage

  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17431356.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / UFT(R) drug; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; 7673326042 / irinotecan; Q573I9DVLP / Leucovorin; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


67. Wu JH, Rong ZX, Zhu DJ, Chen XW, Ren BJ: [Laparoscopic anterior resection of rectal carcinoma with preservation of the left colonic artery]. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun;29(6):1249-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laparoscopic anterior resection of rectal carcinoma with preservation of the left colonic artery].
  • OBJECTIVE: To evaluate the feasibility and efficacy of laparoscopic anterior resection of rectal carcinoma with preservation of the left colonic artery.
  • METHODS: From February 2006 to February 2009, 52 patients with rectal carcinoma formerly scheduled for Dixon operation (clinical stage I and II) received laparoscopic Dixon surgery.
  • The inferior mesenteric artery, left colonic artery, sigmoid artery or superior rectal artery, and lymph nodes were dissected through the vasa vasorum approach.
  • None of the patients had perforation of the rectum, injuries to blood vessel, ureter or adjacent organs, or anastomotic tension.
  • The dissected lymph nodes in the base of the inferior mesenteric artery showed no cancer cell metastasis, while 4 patients had cancer cell metastasis in the lymph nodes surrounding superior rectal artery.
  • CONCLUSION: Laparoscopic anterior resection of the rectal carcinoma with preservation of the left colonic artery can be completed in patients with rectal carcinoma planning to receive Dixon operation (clinical stage I or II).
  • [MeSH-major] Colon / blood supply. Laparoscopy / methods. Mesenteric Artery, Inferior / surgery. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19726377.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


68. Kam M, Massare J, Gallinger S, Kinzie J, Weaver D, Dingell JD, Esufali S, Bapat B, Tobi M: Peutz-Jeghers syndrome diagnosed in a schizophrenic patient with a large deletion in the STK11 gene. Dig Dis Sci; 2006 Sep;51(9):1567-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Peutz-Jeghers Syndrome / diagnosis. Peutz-Jeghers Syndrome / genetics. Protein-Serine-Threonine Kinases / genetics. Schizophrenia / complications. Sequence Deletion
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / therapy. Antineoplastic Agents / therapeutic use. Colectomy. Duodenal Neoplasms / pathology. Duodenal Neoplasms / therapy. Duodenoscopy. Genetic Linkage. Humans. Male. Middle Aged. RNA / blood. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • MedlinePlus Health Information. consumer health - Schizophrenia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Genet. 1987 Jan;31(1):1-6 [3568428.001]
  • [Cites] Am J Gastroenterol. 2000 Mar;95(3):596-604 [10710046.001]
  • [Cites] Cancer Res. 2002 Apr 15;62(8):2261-6 [11956081.001]
  • [Cites] Dis Colon Rectum. 1993 Oct;36(10):953-7 [8404388.001]
  • [Cites] Mol Cell. 2001 Jun;7(6):1307-19 [11430832.001]
  • [Cites] Nature. 1987 Aug 13-19;328(6131):614-6 [3039373.001]
  • [Cites] Eur J Hum Genet. 2004 May;12(5):415-8 [14970844.001]
  • [Cites] J Neurooncol. 2000 Sep;49(3):187-95 [11212897.001]
  • [Cites] Am J Hum Genet. 1998 Jun;62(6):1290-301 [9585611.001]
  • [Cites] Endoscopy. 1996 Feb;28(2):267 [8739752.001]
  • [Cites] N Engl J Med. 1987 Jun 11;316(24):1511-4 [3587280.001]
  • [Cites] Front Biosci. 1999 Mar 15;4:D329-38 [10077546.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):257-61 [9934767.001]
  • [Cites] Radiographics. 1992 Mar;12(2):365-78 [1561426.001]
  • [Cites] Genomics. 1995 Dec 10;30(3):605-9 [8825650.001]
  • [Cites] Am J Surg Pathol. 1989 Sep;13(9):717-29 [2764221.001]
  • [Cites] Clin Genet. 1999 Aug;56(2):136-41 [10517250.001]
  • [Cites] J Natl Cancer Inst. 1998 Jul 15;90(14):1039-71 [9672254.001]
  • [Cites] J Med Genet. 2004 May;41(5):327-33 [15121768.001]
  • [Cites] Cancer. 1982 Oct 1;50(7):1384-402 [7104978.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):87-90 [8988175.001]
  • [Cites] Dig Dis Sci. 1984 Feb;29(2):178-82 [6321116.001]
  • [Cites] Lancet. 1999 Apr 24;353(9162):1425-30 [10227239.001]
  • [Cites] Psychiatr Genet. 1999 Jun;9(2):111-3 [10412193.001]
  • [Cites] Johns Hopkins Med J. 1975 Feb;136(2):71-82 [1117595.001]
  • [Cites] Hum Hered. 1996 Jul-Aug;46(4):191-6 [8807320.001]
  • (PMID = 16927138.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 63231-63-0 / RNA; EC 2.7.1.- / STK11 protein, human; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


69. Kim CW, Kim JH, Yu CS, Shin US, Park JS, Jung KY, Kim TW, Yoon SN, Lim SB, Kim JC: Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery. Int J Radiat Oncol Biol Phys; 2010 Sep 1;78(1):156-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
  • PURPOSE: The aim of the present study was to compare the influence of preoperative chemoradiotherapy (CRT) with postoperative CRT on the incidence and types of postoperative complications in rectal cancer patients who underwent sphincter-saving resection.
  • RESULTS: There was no between-group difference in age, gender, or cancer stage.
  • [MeSH-major] Adenocarcinoma. Anal Canal / surgery. Neoadjuvant Therapy / methods. Postoperative Complications / etiology. Rectal Neoplasms
  • [MeSH-minor] Adult. Aged. Anastomosis, Surgical. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Capecitabine. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Drug Administration Schedule. Enteritis / etiology. Enteritis / surgery. Female. Fluorouracil / administration & dosage. Fluorouracil / analogs & derivatives. Humans. Ileostomy / statistics & numerical data. Intestinal Obstruction / etiology. Intestinal Obstruction / surgery. Korea. Leucovorin / administration & dosage. Male. Middle Aged. Multivariate Analysis. Preoperative Care. Radiotherapy Dosage. Rectal Fistula / etiology. Rectal Fistula / surgery. Rectovaginal Fistula / etiology. Rectovaginal Fistula / therapy. Rectum / surgery. Urinary Bladder Fistula / etiology. Urinary Bladder Fistula / surgery. Young Adult

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20106604.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


70. Fucini C, Pucciani F, Elbetti C, Gattai R, Russo A: Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard? World J Surg; 2010 Jul;34(7):1609-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard?
  • BACKGROUND: Preoperative chemoradiation followed by total mesorectal excision (TME) has become a standard treatment of preoperatively staged T3 low rectal cancers in many institutions; however, a direct comparison of generalized preoperative versus selective adjuvant chemoradiation has never been assessed in a clinical practice setting.
  • PATIENTS: Over a 4-year period, 80 patients with T3 primary low adenocarcinoma of the rectum, judged operable at preoperative staging, were offered preoperative chemoradiation.
  • CONCLUSIONS: In T3 operable low rectal cancers, selective postoperative radiochemotherapy yielded similar long-term results regarding recurrence rate and survival as extended preoperative chemoradiation.
  • [MeSH-major] Adenocarcinoma / surgery. Neoadjuvant Therapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Humans. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Postoperative Complications / epidemiology. Radiotherapy Dosage. Radiotherapy, Adjuvant

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 2006 Mar;49(3):345-52 [16532369.001]
  • [Cites] Cancer. 1993 Jun 1;71(11):3690-6 [8490919.001]
  • [Cites] Lancet. 1993 Feb 20;341(8843):457-60 [8094488.001]
  • [Cites] Cancer. 1984 May 1;53(9):1811-8 [6423263.001]
  • [Cites] Dis Colon Rectum. 1994 Feb;37(2 Suppl):S62-8 [8313796.001]
  • [Cites] Ann Surg. 2002 Jul;236(1):75-81 [12131088.001]
  • [Cites] Ann Surg. 2007 Nov;246(5):693-701 [17968156.001]
  • [Cites] Dis Colon Rectum. 2006 Jan;49(1):12-9 [16292664.001]
  • [Cites] Dis Colon Rectum. 2003 Mar;46(3):298-304 [12626903.001]
  • [Cites] J Clin Oncol. 2008 Jan 20;26(3):350-1 [18202407.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):369-77 [17118570.001]
  • [Cites] J Clin Oncol. 2008 Jan 20;26(3):368-73 [18202411.001]
  • [Cites] Oncol Rep. 2001 May-Jun;8(3):497-500 [11295069.001]
  • [Cites] Lancet. 2009 Mar 7;373(9666):811-20 [19269519.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2007 Nov;19(9):687-92 [17719756.001]
  • [Cites] Ann Surg. 1979 Apr;189(4):496-502 [443905.001]
  • [Cites] Cancer. 1994 Jan 15;73(2):273-80 [8293388.001]
  • [Cites] Cancer. 1986 Jul 15;58(2):352-9 [3521832.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] Dis Colon Rectum. 1999 Oct;42(10):1265-71 [10528762.001]
  • [Cites] N Engl J Med. 1994 Aug 25;331(8):502-7 [8041415.001]
  • [Cites] Dis Colon Rectum. 2002 Jul;45(7):895-903 [12130878.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1075-80 [11072165.001]
  • [Cites] Dis Colon Rectum. 1999 Sep;42(9):1168-75 [10496557.001]
  • [Cites] Dis Colon Rectum. 1997 Feb;40(2):131-9 [9075745.001]
  • [Cites] Am J Clin Oncol. 2001 Apr;24(2):107-12 [11319280.001]
  • (PMID = 20213202.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


71. Okamoto T, Toné S, Kanouchi H, Miyawaki C, Ono S, Minatogawa Y: Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue : Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan and its analogue. Cytotechnology; 2007 Jun;54(2):107-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This enzyme is induced by IFN-gamma in the mouse rectal carcinoma cell line CMT-93.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FASEB J. 1991 Aug;5(11):2516-22 [1907934.001]
  • [Cites] Nat Med. 2005 Mar;11(3):312-9 [15711557.001]
  • [Cites] Life Sci. 1987 Jul 20;41(3):273-80 [3110526.001]
  • [Cites] J Biol Chem. 1988 Feb 5;263(4):2041-8 [3123485.001]
  • [Cites] J Biol Chem. 1986 Mar 15;261(8):3648-53 [2419335.001]
  • [Cites] J Biol Chem. 1978 Jul 10;253(13):4700-6 [26687.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 [388439.001]
  • [Cites] Nat Rev Immunol. 2004 Oct;4(10):762-74 [15459668.001]
  • [Cites] J Exp Med. 1999 May 3;189(9):1363-72 [10224276.001]
  • [Cites] Cytokine. 1999 Apr;11(4):305-12 [10328870.001]
  • [Cites] Science. 1998 Aug 21;281(5380):1191-3 [9712583.001]
  • [Cites] J Biol Chem. 1996 Aug 9;271(32):19140-5 [8702590.001]
  • [Cites] J Interferon Cytokine Res. 1995 Jun;15(6):517-26 [7553221.001]
  • [Cites] Int J Cancer. 1995 Jan 3;60(1):115-22 [7814143.001]
  • [Cites] J Biol Chem. 1993 Mar 5;268(7):5077-84 [8444884.001]
  • [Cites] Int J Cancer. 2002 Sep 10;101(2):151-5 [12209992.001]
  • [Cites] Ann Clin Biochem. 2001 May;38(Pt 3):242-51 [11392499.001]
  • [Cites] Biochem J. 2001 Apr 15;355(Pt 2):425-9 [11284730.001]
  • [Cites] Biochem Biophys Res Commun. 1992 Nov 30;189(1):530-6 [1449503.001]
  • (PMID = 19003025.001).
  • [ISSN] 0920-9069
  • [Journal-full-title] Cytotechnology
  • [ISO-abbreviation] Cytotechnology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC2267499
  •  go-up   go-down


72. Kibil W, Kłek S, Gurda-Duda A, Kopciński P, Kulig J: [The value of endorectal ultrasound (ERUS) in the assessment of the clinical severity of ulcerative colitis]. Przegl Lek; 2007;64(1):5-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: Endorectal ultrasonography (ERUS) represents a relatively new diagnostic tool enabling easy and precise assessment of rectal wall lesions, used mostly in diagnosing of the carcinoma of the rectum.
  • [MeSH-major] Colitis, Ulcerative / ultrasonography. Endosonography. Rectum / ultrasonography

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18183824.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


73. Huh JW, Kim YJ, Kim HR: Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis. World J Gastroenterol; 2009 Feb 14;15(6):756-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis.
  • A 68-year-old man underwent laparoscopic low anterior resection for rectal carcinoma in December 2006.
  • Nearly 19 mo after the operation, he developed recurrent rectal cancer with peritoneal metastasis.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / surgery. Organoplatinum Compounds / therapeutic use. Peritoneal Neoplasms / secondary. Rectal Neoplasms / drug therapy. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Combined Modality Therapy. Fluorouracil / therapeutic use. Humans. Laparoscopy. Leucovorin / therapeutic use. Male. Neoplasm Metastasis / drug therapy. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Surg. 2000 Jun;66(6):561-8 [10888132.001]
  • [Cites] Eur J Surg Oncol. 2001 Feb;27(1):65-73 [11237495.001]
  • [Cites] J Surg Oncol. 2003 May;83(1):5-12; discussion 12-3 [12722090.001]
  • [Cites] J Clin Oncol. 2003 Oct 15;21(20):3737-43 [14551293.001]
  • [Cites] J Clin Oncol. 2003 Dec 15;21(24):4560-7 [14673042.001]
  • [Cites] Ann Surg. 2008 Nov;248(5):829-35 [18948811.001]
  • [Cites] Br J Surg. 2004 Jun;91(6):747-54 [15164446.001]
  • [Cites] World J Gastroenterol. 2006 Oct 14;12(38):6124-7 [17036382.001]
  • [Cites] World J Surg. 2006 Dec;30(12):2132-5 [17006612.001]
  • [Cites] Ann Surg Oncol. 2007 Feb;14(2):509-14 [17096054.001]
  • [Cites] Ann Surg Oncol. 2004 Apr;11(4):387-92 [15070598.001]
  • (PMID = 19222104.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  • [Other-IDs] NLM/ PMC2653448
  •  go-up   go-down


74. Chen KY, Xiang GA, Wang HN, Xiao FL: [Simultaneous laparoscopic excision for the treatment of rectal carcinoma and the synchronous hepatic metastasis]. Zhonghua Zhong Liu Za Zhi; 2009 Jan;31(1):69-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Simultaneous laparoscopic excision for the treatment of rectal carcinoma and the synchronous hepatic metastasis].
  • OBJECTIVE: To evaluate the therapeutic efficacy of simultaneous laparoscopic excision for the treatment of rectal carcinoma and synchronous hepatic metastasis.
  • METHODS: Totally 38 patients with rectal carcinoma and synchronous hepatic metastasis detected by CT scan were included in this study.
  • Among them, 23 patients in the group A were treated with laparoscopic surgery, and the other 18 patients in the group B with traditional abdominal operation to resect the rectal tumor and hepatic metastasis simultaneously.
  • CONCLUSION: Simultaneous laparoscopic excision of rectal carcinoma and synchronous hepatic metastasis is safe, effective and minimally invasive with a similar survival achieved by traditional open abdominal operation.
  • [MeSH-major] Adenocarcinoma / surgery. Laparoscopy / methods. Liver Neoplasms / surgery. Rectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19538876.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


75. Basu KS, Bahl A, Subramani V, Sharma DN, Rath GK, Julka PK: Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma. J Cancer Res Ther; 2009 Apr-Jun;5(2):78-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
  • AIM: The main objective of this study was to analyze the radiobiological effect of different treatment strategies on high-risk prostate adenocarcinoma.
  • MATERIALS AND METHODS: Ten cases of high-risk prostate adenocarcinoma were selected for this dosimetric study.
  • Four different treatment strategies used for treating prostate cancer were compared.
  • RESULTS: An NTCP of 10.7 +/- 0.99%, 8.36 +/- 0.66%, 6.72 +/- 0.85%, and 1.45 +/- 0.11% for the bladder and 14.9 +/- 0.99%, 14.04 +/- 0.66%, 11.38 +/- 0.85%, 5.12 +/- 0.11% for the rectum was seen with 3D + 3DCRT, 3D + IMRT, IMRT + IMRT, and SIBIMRT respectively.
  • It should be the technique of choice for dose escalation in prostate carcinoma.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Probability. Prostatic Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19542662.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


76. van Baardewijk LJ, Idenburg FJ, Clahsen PC, Möllers MJ: [Von Meyenburg complexes in the liver: not metastases]. Ned Tijdschr Geneeskd; 2010;154:A1674
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 74-year-old woman underwent a laparotomy for a rectal carcinoma.
  • Intraoperative frozen section analysis to differentiate between malignant and benign lesions has a sensitivity of 97% and a specificity of 99%.
  • The patient underwent total mesorectal excision and follow-up after 3, 7 and 9 months did not reveal any indications of recurrent colorectal cancer or metastases.
  • [MeSH-major] Hamartoma / diagnosis. Liver Diseases / diagnosis. Liver Neoplasms / diagnosis
  • [MeSH-minor] Aged. Bile Ducts / abnormalities. Bile Ducts / pathology. Carcinoma / pathology. Carcinoma / surgery. Diagnosis, Differential. Female. Humans. Incidental Findings. Liver / pathology. Neoplasm Metastasis / diagnosis. Neoplasm Metastasis / pathology. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Liver Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20619020.001).
  • [ISSN] 1876-8784
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


77. Wells BJ, Stotland P, Ko MA, Al-Sukhni W, Wunder J, Ferguson P, Lipa J, Last L, Smith AJ, Swallow CJ: Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol; 2007 Feb;14(2):390-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Results of an aggressive approach to resection of locally recurrent rectal cancer.
  • BACKGROUND: The value of resection for locally recurrent rectal cancer (LRRC) remains controversial.
  • [MeSH-major] Adenocarcinoma / surgery. Colectomy / mortality. Neoplasm Recurrence, Local / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Rectum / pathology. Rectum / surgery. Retrospective Studies. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17063304.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


78. Wentink MQ, Räkers M, Stupart DA, Algar U, Ramesar R, Goldberg PA: Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa. S Afr J Surg; 2010 Nov;48(4):109-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa.
  • AIM: The purpose of this study was to determine the incidence of colorectal cancer (CRC) in the Northern Cape province of South Africa, and to identify patients with histological and demographic features suggestive of hereditary non-polyposis colon cancer (HNPCC).
  • METHOD: This is a retrospective review of all cases of primary adenocarcinoma of the colon or rectum diagnosed by the two pathology laboratories operating in the Northern Cape between January 2002 and February 2009.
  • The median age at which colorectal cancer was diagnosed was 59 years (range 16-90 years).
  • [MeSH-major] Adenocarcinoma / epidemiology. Adenocarcinoma / pathology. Colorectal Neoplasms, Hereditary Nonpolyposis / epidemiology. Colorectal Neoplasms, Hereditary Nonpolyposis / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Chi-Square Distribution. Female. Humans. Incidence. Male. Microsatellite Instability. Middle Aged. Neoplasm Staging. Retrospective Studies. South Africa / epidemiology. Statistics, Nonparametric

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21542398.001).
  • [ISSN] 0038-2361
  • [Journal-full-title] South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie
  • [ISO-abbreviation] S Afr J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] South Africa
  •  go-up   go-down


79. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM): Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys; 2006 Mar 15;64(4):1129-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
  • PURPOSE: The combination of irradiation and total mesorectal excision for rectal carcinoma has significantly lowered the incidence of local recurrence.
  • However, a new problem is represented by the patient with locally recurrent cancer who has received previous irradiation to the pelvis.
  • The aim of this multicenter phase II study is to evaluate the response rate, resectability rate, local control, and treatment-related toxicity of preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis.
  • METHODS AND MATERIALS: Patients with histologically proven pelvic recurrence of rectal carcinoma, with the absence of extrapelvic disease or bony involvement and previous pelvic irradiation with doses < or =55 Gy; age > or =18 years; performance status (PS) (Karnofsky) > or =60, and who gave institutional review board-approved written informed consent were treated by preoperative chemoradiation.
  • [MeSH-major] Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / radiotherapy. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16414206.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Quinazolines; 0 / Thiophenes; FCB9EGG971 / raltitrexed; U3P01618RT / Fluorouracil
  •  go-up   go-down


80. Lotter O, Amr A, Safi F: Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay. Ger Med Sci; 2010;8:Doc24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassay.
  • In the following study we examined if elevated levels of p53 correlate with worse prognosis in colorectal cancer.
  • METHODS: We have quantified the protein, using an immunoluminometric assay, in 144 cytosols of primary sporadic colorectal cancer tissues and in 96 specimen of normal mucosa.
  • CONCLUSION: Our investigation revealed that p53-overexpression as measured by a luminometric immunoassay, is not a useful predictor of prognosis in patients with colorectal adenocarcinoma.

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 1999 Nov-Dec;19(6B):5015-22 [10697504.001]
  • [Cites] Br J Cancer. 1993 Aug;68(2):399-402 [8347496.001]
  • [Cites] Nature. 1979 Mar 15;278(5701):261-3 [218111.001]
  • [Cites] J Natl Cancer Inst. 1988 Jun 15;80(8):586-91 [3373549.001]
  • [Cites] Dis Colon Rectum. 1993 Jul;36(7):636-43; discussion 643-4 [8348848.001]
  • [Cites] J Natl Cancer Inst. 1994 May 4;86(9):681-7 [8158699.001]
  • [Cites] Br J Cancer. 1994 May;69(5):943-6 [8180028.001]
  • [Cites] Am J Clin Pathol. 1994 Jun;101(6):684-8 [8209852.001]
  • [Cites] Science. 1994 Dec 16;266(5192):1821-8 [7997877.001]
  • [Cites] Br J Cancer. 1995 May;71(5):1013-7 [7734292.001]
  • [Cites] Exp Mol Pathol. 1995 Feb;62(1):52-62 [7556591.001]
  • [Cites] Int J Cancer. 1996 Apr 22;69(2):125-30 [8608980.001]
  • [Cites] Cancer. 1995 Oct 1;76(7):1201-8 [8630898.001]
  • [Cites] Eur J Cancer. 1996 May;32A(5):802-6 [9081357.001]
  • [Cites] Br J Cancer. 1996 Jul;74(2):216-23 [8688324.001]
  • [Cites] Br J Biomed Sci. 1996 Jun;53(2):101-7 [8757686.001]
  • [Cites] Scand J Gastroenterol. 1996 May;31(5):481-9 [8734346.001]
  • [Cites] Eur J Cancer. 2007 Jun;43(9):1348-60 [17512720.001]
  • [Cites] Int J Colorectal Dis. 2008 Jun;23(6):595-600 [18330580.001]
  • [Cites] Anticancer Res. 2009 Feb;29(2):785-91 [19331236.001]
  • [Cites] Ann Oncol. 2000 Apr;11(4):393-7 [10847456.001]
  • [Cites] EMBO J. 1990 May;9(5):1595-602 [1691710.001]
  • [Cites] Nature. 1990 Dec 20-27;348(6303):681-2 [2259380.001]
  • [Cites] Nature. 1992 Jul 2;358(6381):15-6 [1614522.001]
  • [Cites] Cancer Res. 1992 Sep 1;52(17):4828-31 [1324796.001]
  • [Cites] J Pathol. 1992 Apr;166(4):329-30 [1517889.001]
  • [Cites] Lancet. 1992 Dec 5;340(8832):1369-73 [1360088.001]
  • [Cites] Hum Pathol. 2010 Jun;41(6):867-76 [20129645.001]
  • (PMID = 21063465.001).
  • [ISSN] 1612-3174
  • [Journal-full-title] German medical science : GMS e-journal
  • [ISO-abbreviation] Ger Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Luminescent Proteins; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53
  • [Other-IDs] NLM/ PMC2975257
  • [Keywords] NOTNLM ; colorectal cancer / p53-protein / prognosis / tumor markers
  •  go-up   go-down


81. Cao J, Xia J, Wang H, DU H, Li WL: [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar;10(2):177-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma].
  • OBJECTIVE: To investigate the relationship between the expression of fragile histidine triad (FHIT) protein and the clinicopathological characteristics of rectal carcinoma.
  • The relationship between FHIT protein expression and Bcl-2, Bax and survivin expression, as well as cell apoptosis in rectal carcinoma were explored.
  • METHODS: Tissue microarray and immunohistochemistry SP were used to detect the expression of FHIT, Bcl-2, Bax and Survivin in 16 cases of normal rectal tissue, 16 cases of rectal adenoma and 80 cases of rectal carcinoma.
  • TUNEL was used to detect apoptosis index (AI) in 80 cases of rectal carcinoma.
  • RESULTS: The positive rates of FHIT expression in normal rectal tissue, rectal adenoma and adenocarcinoma were 93.8%, 75.0% and 46.3% respectively.
  • The expression of FHIT was positively correlated with that of Bcl-2, Bax and survivin in rectal cancer.
  • CONCLUSIONS: The reduction of FHIT protein expression may play an important role in the development of rectal carcinoma, and FHIT protein may be associated with the regulation of cell apoptosis.
  • [MeSH-major] Acid Anhydride Hydrolases / metabolism. Apoptosis. Neoplasm Proteins / metabolism. Rectal Neoplasms / metabolism. Rectal Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Inhibitor of Apoptosis Proteins. Lymphatic Metastasis. Male. Microtubule-Associated Proteins / metabolism. Middle Aged. Neoplasm Staging. Protein Array Analysis. bcl-2-Associated X Protein / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17380463.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins; 0 / bcl-2-Associated X Protein; 0 / fragile histidine triad protein; EC 3.6.- / Acid Anhydride Hydrolases
  •  go-up   go-down


82. Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ: Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation. Pharmacogenomics; 2006 Jan;7(1):67-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.
  • PURPOSE: Stage II and III adenocarcinoma of the rectum has an overall 5-year survival rate of approximately 50%, and tumor recurrence remains a major problem despite an improvement in local control through chemotherapy and radiation.
  • In this study, we tested whether a specific pattern of 21 polymorphisms in 18 genes involved in the critical pathways of cancer progression (i.e., drug metabolism, tumor microenvironment, cell cycle regulation, and DNA repair) will predict the risk of tumor recurrence in rectal cancer patients treated with chemoradiation.
  • PATIENTS AND METHODS: A total of 90 patients with Stage II or III rectal cancer treated with chemoradiation were genotyped using polymerase chain reaction (PCR)-based techniques for 21 polymorphisms.
  • A larger prospective study is needed to validate these preliminary data using germline polymorphisms on tumor recurrences in rectal cancer patients treated with chemoradiation.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Gene Expression Profiling. Rectal Neoplasms / genetics

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16354126.001).
  • [ISSN] 1462-2416
  • [Journal-full-title] Pharmacogenomics
  • [ISO-abbreviation] Pharmacogenomics
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / K24CA8275401; United States / NCI NIH HHS / CA / P30CA14039; United States / NCI NIH HHS / CA / R01CA105145; United States / NCI NIH HHS / CA / R01CA82655
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / DNA-Binding Proteins; 0 / Interleukin-8; 0 / Transforming Growth Factor beta; 0 / X-ray repair cross complementing protein 3; EC 1.14.99.1 / Cyclooxygenase 2; EC 2.5.1.18 / GSTP1 protein, human; EC 2.5.1.18 / Glutathione S-Transferase pi; EC 3.1.- / ERCC1 protein, human; EC 3.1.- / Endonucleases
  •  go-up   go-down


83. Balbinotti RA, Ribeiro U Jr, Sakai P, Safatle-Ribeiro AV, Balbinotti SS, Scapulatempo C, Alves VA, Corbett CE, Carrilho FJ: hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps. Anticancer Res; 2007 Nov-Dec;27(6C):4465-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutations in the mismatch repair (MMR) enzymes hMLH1, hMSH2 and hMSH6 are recognized causes of hereditary non-polyposis colorectal cancer and act by inducing a mutator phenotype characterized by microsatellite instability (MSI).
  • Cox-2 is an inducible enzyme that regulates prostaglandin synthesis and it is overexpressed at sites of inflammation, in colorectal adenomatous polyps and cancer.
  • PATIENTS AND METHODS: One hundred and sixty-seven colonic polyps, 6 normal colonic mucosa samples, and 23 samples of colorectal adenocarcinoma were used in this study.
  • All patients had no family history of colorectal cancer.
  • CONCLUSION: Loss of hMLH1 and hMLH2 immunoexpression in adenomas is relatively frequent in patients without colorectal cancer family history.
  • [MeSH-minor] Adenocarcinoma / metabolism. Adult. Aged. Aged, 80 and over. Colorectal Neoplasms / metabolism. Female. Humans. Immunohistochemistry. Male. Middle Aged. Rectum / pathology

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18214062.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / MLH1 protein, human; 0 / Nuclear Proteins; EC 1.14.99.1 / Cyclooxygenase 2; EC 3.6.1.3 / MSH2 protein, human; EC 3.6.1.3 / MutS Homolog 2 Protein
  •  go-up   go-down


84. Parikh JH, Barton DP, Ind TE, Sohaib SA: MR imaging features of vaginal malignancies. Radiographics; 2008 Jan-Feb;28(1):49-63; quiz 322
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Squamous cell carcinoma makes up about 85% of primary vaginal malignancies.
  • At magnetic resonance (MR) imaging, squamous cell carcinoma has intermediate signal intensity on T2-weighted images and low signal intensity on T1-weighted images.
  • The tumors that account for the remaining 15% of primary vaginal malignancies are adenocarcinoma, melanoma, and sarcomas.
  • Most vaginal metastases occur by means of direct local spread from the cervix, uterus, or rectum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Squamous Cell / diagnosis. Image Enhancement / methods. Magnetic Resonance Imaging / methods. Vagina / pathology. Vaginal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18203930.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 55
  •  go-up   go-down


85. Zheng YL, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Liang JY, Lu MD: Value of contrast-enhanced ultrasonography in assessing the vascularity of liver metastases: comparison with contrast-enhanced computed tomography. J Ultrasound Med; 2010 Oct;29(10):1403-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Both CEUS and CECT examinations were performed on 70 patients with liver metastases, which were from colon carcinoma in 31, rectal carcinoma in 17, pancreatic carcinoma in 5, and others in 17.
  • [MeSH-minor] Adult. Aged. Colonic Neoplasms / pathology. Female. Humans. Image Enhancement. Image Processing, Computer-Assisted. Male. Middle Aged. Pancreatic Neoplasms / pathology. Phospholipids. Radiographic Image Enhancement / methods. Rectal Neoplasms / pathology. Sulfur Hexafluoride. Tomography, X-Ray Computed / methods. Ultrasonography, Interventional / methods

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. SULFUR HEXAFLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20876893.001).
  • [ISSN] 1550-9613
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Phospholipids; 0 / contrast agent BR1; WS7LR3I1D6 / Sulfur Hexafluoride
  •  go-up   go-down


86. Schneider AR, Seifert H, Trojan J, Stein J, Hoepffner NM: Frequency of colorectal polyps in patients with sporadic adenomas or adenocarcinomas of the papilla of vater--an age-matched, controlled study. Z Gastroenterol; 2005 Oct;43(10):1123-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The carcinogenesis of these tumors seems to be fairly analogous to the genetic mechanisms which have been described for colorectal carcinoma.
  • Colonoscopy detected rectal carcinoma in 2 patients (8%) of the study group.
  • However, the finding of 2 rectal carcinomas among patients with ampullary neoplasms supports the place of screening colonoscopy for the diagnostic work-up of ampullary tumors.
  • [MeSH-major] Adenocarcinoma / complications. Adenoma / complications. Ampulla of Vater. Common Bile Duct Neoplasms / complications. Intestinal Polyps / epidemiology
  • [MeSH-minor] Adenoma, Villous / complications. Adenoma, Villous / surgery. Adenomatous Polyposis Coli / epidemiology. Adult. Aged. Aged, 80 and over. Colonic Polyps / diagnosis. Colonic Polyps / epidemiology. Colonoscopy. Colorectal Neoplasms / diagnosis. Colorectal Neoplasms / epidemiology. Data Interpretation, Statistical. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prevalence. Retrospective Studies. Risk Factors. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16220451.001).
  • [ISSN] 0044-2771
  • [Journal-full-title] Zeitschrift für Gastroenterologie
  • [ISO-abbreviation] Z Gastroenterol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Mäkelä JT, Kiviniemi H: Clinicopathological features of colorectal cancer in patients under 40 years of age. Int J Colorectal Dis; 2010 Jul;25(7):823-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological features of colorectal cancer in patients under 40 years of age.
  • OBJECTIVE: The aim was to identify the clinical factors and tumour characteristics that predict survival in patients younger than 40 years with colorectal adenocarcinoma.
  • MATERIAL AND METHODS: Fifty-nine patients with colorectal cancer aged under 40 years were identified from a computer database, and their clinical variables were analysed.
  • RESULTS: The prevalence of positive family history of cancer was 27%, and predisposing factors were present in 31% of the patients.
  • The cumulative 5-year survival of men, 45%, was significantly worse than that of women, 73%, and this phenomenon was closely related to more distended lymphatic and venous invasion of cancer in men.
  • CONCLUSIONS: Young men with colorectal cancer in Northern Finland have poorer prognosis than women.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2009 Mar 24;100(6):881-7 [19259089.001]
  • [Cites] Int J Colorectal Dis. 2006 Sep;21(6):596-601 [16284773.001]
  • [Cites] Arch Surg. 1995 Oct;130(10):1062-7 [7575117.001]
  • [Cites] Br J Surg. 2003 Feb;90(2):205-14 [12555297.001]
  • [Cites] J Am Coll Surg. 1996 Aug;183(2):105-12 [8696540.001]
  • [Cites] Br J Surg. 1998 Sep;85(9):1255-9 [9752871.001]
  • [Cites] Gastroenterology. 1988 Feb;94(2):395-400 [3335314.001]
  • [Cites] N Engl J Med. 1994 Dec 22;331(25):1669-74 [7969357.001]
  • [Cites] N Engl J Med. 2009 Feb 5;360(6):563-72 [19196673.001]
  • [Cites] Dis Colon Rectum. 1986 May;29(5):322-5 [3009108.001]
  • [Cites] Dis Colon Rectum. 1997 Jan;40(1):3-10 [9102257.001]
  • [Cites] Dis Colon Rectum. 1991 Apr;34(4):343-6 [1706654.001]
  • [Cites] Am J Surg. 2004 Mar;187(3):343-8 [15006562.001]
  • [Cites] Dis Colon Rectum. 2006 Sep;49(9):1275-83 [16912910.001]
  • [Cites] Dis Colon Rectum. 2000 Sep;43(9):1222-6 [11005487.001]
  • [Cites] Am J Gastroenterol. 1997 Sep;92(9):1505-9 [9317073.001]
  • [Cites] Dis Colon Rectum. 1996 Sep;39(9):1004-7 [8797650.001]
  • [Cites] Dis Colon Rectum. 1980 Jul-Aug;23(5):327-36 [7398507.001]
  • [Cites] Dis Colon Rectum. 1989 Oct;32(10):843-6 [2791769.001]
  • [Cites] Dis Colon Rectum. 1990 May;33(5):363-6 [2328623.001]
  • [Cites] Scand J Gastroenterol. 1984 Jul;19(5):634-8 [6474085.001]
  • [Cites] Ann Surg. 1967 Sep;166(3):420-7 [6039601.001]
  • [Cites] Ann Oncol. 2005 Aug;16(8):1305-10 [15857840.001]
  • [Cites] Cancer. 1988 Feb 15;61(4):835-40 [3338041.001]
  • [Cites] Dis Colon Rectum. 2001 Mar;44(3):380-7 [11289284.001]
  • (PMID = 20217423.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


88. Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE: Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum; 2007 Feb;50(2):168-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesorectal grades predict recurrences after curative resection for rectal cancer.
  • PURPOSE: Local recurrence after curative excision for rectal cancer is frequently regarded as a failure of surgery.
  • METHODS: All patients undergoing resection for primary adenocarcinoma of the rectum had a mesorectal grading prospectively applied to their resection specimens, according to the classification proposed by Quirke et al. (Grades 1-3; 3 is the best).
  • CONCLUSIONS: The macroscopic quality of mesorectum after curative excision of rectal cancer is an important predictor of local and overall recurrences.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Digestive System Surgical Procedures / methods. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Predictive Value of Tests. Proportional Hazards Models. Prospective Studies. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17160574.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Lahat A, Yanai H, Sakhnini E, Menachem Y, Bar-Meir S: Role of colonoscopy in patients with persistent acute diverticulitis. World J Gastroenterol; 2008 May 7;14(17):2763-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Three hundred and six patients were hospitalized between July 2000 and December 2006 with the diagnosis of acute diverticulitis.
  • [MeSH-major] Adenocarcinoma / pathology. Colonic Neoplasms / pathology. Colonoscopy. Diverticulitis, Colonic / pathology. Foreign-Body Reaction / pathology

  • Genetic Alliance. consumer health - Diverticulitis.
  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastrointest Endosc. 1980 May;26(2 Suppl):20S-21S [7390117.001]
  • [Cites] Am J Gastroenterol. 2005 Apr;100(4):910-7 [15784040.001]
  • [Cites] World J Gastroenterol. 2006 May 14;12(18):2932-5 [16718822.001]
  • [Cites] Endoscopy. 2007 Jun;39(6):521-4 [17554647.001]
  • [Cites] Dis Colon Rectum. 2000 Mar;43(3):290-7 [10733108.001]
  • [Cites] Gastroenterol Clin North Am. 2001 Jun;30(2):475-96 [11432301.001]
  • [Cites] N Engl J Med. 1980 Feb 7;302(6):324-31 [6985709.001]
  • [Cites] Gut. 1969 May;10(5):336-44 [5771665.001]
  • [Cites] Br J Surg. 1973 Aug;60(8):633-5 [4724205.001]
  • [Cites] Clin Gastroenterol. 1975 Jan;4(1):3-21 [1109818.001]
  • [Cites] Clin Gastroenterol. 1975 Jan;4(1):53-69 [1109820.001]
  • [Cites] Dis Colon Rectum. 1975 Oct;18(7):626-7 [1081038.001]
  • [Cites] Gastrointest Endosc. 1977 May;23(4):192-3 [301108.001]
  • [Cites] Endoscopy. 2004 Jun;36(6):504-7 [15202046.001]
  • (PMID = 18461662.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Other-IDs] NLM/ PMC2709057
  •  go-up   go-down


90. Baća I, Perko Z, Bokan I, Mimica Z, Petricević A, Druzijanić N, Situm M: Technique and survival after laparoscopically assisted right hemicolectomy. Surg Endosc; 2005 May;19(5):650-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The role of laparoscopic colon resection in the management of colon cancer is still controversial.
  • METHODS: Between March 1993 and July 2003, we performed laparoscopic right hemicolectomy in 56 patients with right colon carcinoma.
  • CONCLUSIONS: Our results show that laparoscopic right hemicolectomy for colon cancer can be performed safely.
  • [MeSH-major] Adenocarcinoma / surgery. Colectomy / methods. Colonic Neoplasms / surgery. Laparoscopy / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Colitis / surgery. Colonic Polyps / surgery. Disease-Free Survival. Female. Humans. Life Tables. Lymph Node Excision. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Recurrence, Local. Postoperative Complications / epidemiology. Prognosis. Proportional Hazards Models. Retrospective Studies. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Endosc. 2002 Apr;16(4):607-10 [11972198.001]
  • [Cites] Dis Colon Rectum. 1996 Oct;39(10 Suppl):S53-8 [8831547.001]
  • [Cites] Dis Colon Rectum. 1996 Oct;39(10 Suppl):S20-3 [8831542.001]
  • [Cites] Ann Surg. 2000 Aug;232(2):181-6 [10903594.001]
  • [Cites] Surg Laparosc Endosc. 1991 Sep;1(3):144-50 [1688289.001]
  • [Cites] Zentralbl Chir. 1997;122(7):569-76; discussion 576-7 [9340965.001]
  • [Cites] Ann Surg. 1998 Mar;227(3):326-34 [9527054.001]
  • [Cites] Dis Colon Rectum. 1983 Sep;26(9):571-2 [6223795.001]
  • [Cites] Surg Endosc. 2000 Jul;14(7):612-6 [10948295.001]
  • [Cites] Minerva Chir. 2003 Aug;58(4):491-502, 502-7 [14603161.001]
  • [Cites] Cancer. 1981 Mar 15;47(6):1424-9 [7226068.001]
  • [Cites] Surg Endosc. 1998 Jul;12(7):963-7 [9632871.001]
  • [Cites] Ann Surg. 1999 Apr;229(4):487-92 [10203080.001]
  • [Cites] J Surg Oncol. 1985 Nov;30(3):139-44 [3908826.001]
  • [Cites] Surg Endosc. 2002 Apr;16(4):596-602 [11972196.001]
  • [Cites] Br J Surg. 1998 Oct;85(10):1439-42 [9782033.001]
  • [Cites] Surg Endosc. 2002 Aug;16(8):1158-61 [11984684.001]
  • [Cites] Br J Surg. 1997 Mar;84(3):358-61 [9117307.001]
  • [Cites] Lancet. 1994 Jul 2;344(8914):58 [7912321.001]
  • [Cites] Dis Colon Rectum. 2000 Mar;43(3):326-32 [10733113.001]
  • [Cites] Am J Surg. 1984 Sep;148(3):303-7 [6236703.001]
  • [Cites] J Am Coll Surg. 1998 Jul;187(1):46-54; discussion 54-5 [9660024.001]
  • [Cites] Surgery. 1996 Mar;119(3):316-25 [8619187.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2224-9 [12103285.001]
  • [Cites] Dis Colon Rectum. 2001 May;44(5):638-46 [11357021.001]
  • [Cites] Surgery. 1999 Jan;125(1):67-72 [9889800.001]
  • [Cites] Dis Colon Rectum. 1996 Feb;39(2):200-7 [8620788.001]
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):1-8 [10813116.001]
  • [Cites] Surg Endosc. 1998 Jan;12(1):37-41 [9419300.001]
  • [Cites] Dis Colon Rectum. 1999 Mar;42(3):327-32; discussion 332-3 [10223751.001]
  • [Cites] Chirurg. 2001 Mar;72(3):227-35 [11317440.001]
  • [Cites] Int J Colorectal Dis. 1999 Aug;14(3):158-63 [10460907.001]
  • (PMID = 15776206.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


91. Langholz E: Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol; 2010 Mar;3(2):77-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At diagnosis behaviour is inflammatory in 70% of patients.
  • The incidence of colorectal cancer (CRC) in UC seems to be decreasing.
  • Patients with small bowel CD are also at increased risk of small bowel adenocarcinoma.
  • Further studies are needed to develop the best strategy for the reduction of mortality and cancer risk in IBD.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21180592.001).
  • [ISSN] 1756-2848
  • [Journal-full-title] Therapeutic advances in gastroenterology
  • [ISO-abbreviation] Therap Adv Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3002570
  • [Keywords] NOTNLM ; colorectal cancer / disease course / epidemiology / inflammatory bowel disease / mortality / prognosis
  •  go-up   go-down


92. Miki C, Inoue Y, Hiro J, Ojima E, Araki T, Uchida K, Kusunoki M: Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study. Dis Colon Rectum; 2006 Nov;49(11):1710-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
  • PURPOSE: There is no marker capable of differentiating patients with Dukes A and B colorectal cancer with aggressive diseases from those with indolent diseases.
  • METHODS: Blood samples of 147 colorectal cancer patients were obtained and the serum concentration of hepatocyte growth factor was measured.
  • [MeSH-minor] Adenocarcinoma / blood. Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Aged. Biomarkers / blood. Female. Humans. Japan / epidemiology. Liver Neoplasms / secondary. Lymphatic Metastasis. Male. Neoplasm Invasiveness. Neoplasm Recurrence, Local / blood. Prognosis. Survival Analysis

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16990975.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Carcinoembryonic Antigen; 67256-21-7 / Hepatocyte Growth Factor
  •  go-up   go-down


93. Bakx R, Emous M, Legemate DA, Machado M, Zoetmulder FA, van Tets WF, Bemelman WA, Slors JF, van Lanschot JJ: Categorization of major and minor complications in the treatment of patients with resectable rectal cancer using short-term pre-operative radiotherapy and total mesorectal excision: a Delphi round. Colorectal Dis; 2006 May;8(4):302-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Categorization of major and minor complications in the treatment of patients with resectable rectal cancer using short-term pre-operative radiotherapy and total mesorectal excision: a Delphi round.
  • BACKGROUND: To properly balance the benefit (reduction of local recurrence) of short-term pre-operative radiotherapy for resectable rectal cancer against its harm (complications), a consensus concerning the severity of complications is required.
  • The aim of this study was to reach consensus regarding major and minor complications after short-term radiotherapy followed by total mesorectal excision in the treatment of rectal carcinoma, using the Delphi technique.
  • METHODS: A Delphi round was performed in cooperation with 21 colo-rectal surgeons from the Netherlands, United Kingdom and Sweden.
  • The key-question was: 'Which of the predefined complications, caused or substantially aggravated by radiotherapy, are so important (major) that they might lead to the decision to abandon short-term pre-operative radiotherapy (5 x 5Gy) when treating patients with resectable rectal cancer (T1-3N0-2M0)?
  • CONCLUSION: The 13 major and three 'accepted as major' complications can be used to properly balance the benefit and harm of short-term pre-operative radiotherapy in resectable rectal cancer.
  • [MeSH-major] Colorectal Surgery. Consensus. Expert Testimony. Neoadjuvant Therapy / adverse effects. Radiotherapy, Adjuvant / adverse effects. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630234.001).
  • [ISSN] 1462-8910
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


94. de Bruin EC, van de Pas S, Lips EH, van Eijk R, van der Zee MM, Lombaerts M, van Wezel T, Marijnen CA, van Krieken JH, Medema JP, van de Velde CJ, Eilers PH, Peltenburg LT: Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles. BMC Genomics; 2005;6:142
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles.
  • However, the presence of stroma cells in surgically excised carcinoma tissues might obscure the tumor cell-specific gene expression profiles of these samples.
  • In this report, we compared RNAs isolated from macrodissected, of which only surrounding healthy tissue had been removed, and microdissected rectal carcinoma samples by microarray analysis in order to determine the most reliable approach to detect the expression of tumor cell-derived genes by microarray analysis.
  • [MeSH-major] Gene Expression Regulation. Gene Expression Regulation, Neoplastic. Microdissection / methods. Rectal Neoplasms / diagnosis. Rectal Neoplasms / pathology
  • [MeSH-minor] Carcinoma / metabolism. Cluster Analysis. DNA, Complementary / metabolism. Gene Expression Profiling. Humans. Microarray Analysis. RNA / metabolism. RNA, Messenger / metabolism. RNA, Neoplasm / metabolism. Software. Stromal Cells / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biotechnol. 2004 Jan 8;107(1):19-28 [14687968.001]
  • [Cites] Am J Pathol. 2003 Dec;163(6):2191-9 [14633594.001]
  • [Cites] Genomics. 2004 Mar;83(3):508-17 [14962677.001]
  • [Cites] Oncogene. 2004 Apr 1;23(14):2484-98 [14676830.001]
  • [Cites] J Lab Clin Med. 2004 Jun;143(6):344-51 [15192650.001]
  • [Cites] Nucleic Acids Res. 2004;32(19):e146 [15514107.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Mar;87(5):1663-7 [1689846.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9212-7 [10430922.001]
  • [Cites] BMC Bioinformatics. 2005;6:54 [15766384.001]
  • [Cites] J Pathol. 2005 Sep;207(1):61-71 [16007578.001]
  • [Cites] Nucleic Acids Res. 2001 Mar 1;29(5):E29 [11222780.001]
  • [Cites] Am J Pathol. 2001 Jun;158(6):2005-10 [11395378.001]
  • [Cites] Bioinformatics. 2001;17 Suppl 1:S279-87 [11473019.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15149-54 [11742071.001]
  • [Cites] Am J Clin Pathol. 2002 Jan;117(1):109-16 [11789716.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):801-13 [11891179.001]
  • [Cites] Biotechniques. 2002 Jun;32(6):1330-4, 1336, 1338, 1340 [12074164.001]
  • [Cites] BMC Cancer. 2001;1:7 [11481031.001]
  • [Cites] Biotechniques. 2002 Oct;33(4):906-12, 914 [12398200.001]
  • [Cites] Nat Genet. 2003 Jan;33(1):49-54 [12469122.001]
  • [Cites] J Mol Diagn. 2003 Feb;5(1):9-14 [12552074.001]
  • [Cites] Biotechniques. 2003 Feb;34(2):394-400 [12613262.001]
  • [Cites] BMC Genomics. 2003 Mar 23;4(1):11 [12659661.001]
  • [Cites] Oncogene. 2003 Sep 29;22(42):6497-507 [14528274.001]
  • [Cites] Oncogene. 2003 Nov 20;22(52):8487-97 [14627989.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):615-20 [14722351.001]
  • (PMID = 16225673.001).
  • [ISSN] 1471-2164
  • [Journal-full-title] BMC genomics
  • [ISO-abbreviation] BMC Genomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 63231-63-0 / RNA
  • [Other-IDs] NLM/ PMC1283972
  •  go-up   go-down


95. Tateishi S, Arima S, Futami K, Kawahara K, Tachikawa D, Naritomi K, Iwashita A: A clinicopathological investigation of "tumor nodules" in colorectal cancer. Surg Today; 2005;35(5):377-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A clinicopathological investigation of "tumor nodules" in colorectal cancer.
  • The TNM classification of malignant tumors provides a description of how to deal with tn, but there has so far been no description within the Japanese classification of colorectal carcinoma.
  • METHODS: A total of 544 patients who underwent a resection of colorectal adenocarcinoma between 1985 and 1995 were reviewed.
  • RESULTS: Tumor nodules were found in 54 (17.6%) of 307 colon cancer patients, and in 41 (17.3%) of 237 rectal cancer patients.
  • We classified the curability A patients into four groups for both colon and rectal cancer; positive lymph nodes with tn (Group A), negative lymph nodes with tn (Group B), positive lymph nodes without tn (Group C), and negative lymph nodes without tn (Group D).
  • The prognosis was not significantly different between Groups A, B, and C, but it was significantly different between Group D and Groups A, B, and C (P < 0.01) in both the colon and the rectum.
  • [MeSH-major] Adenocarcinoma / pathology. Colorectal Neoplasms / pathology. Lymph Nodes / pathology

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Surg Today. 2006;36(10):944-5 [16998694.001]
  • (PMID = 15864419.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


96. Artifon EL, Sakai P, Ishioka S, Silva AF, Maluf F, Chaves D, Matuguma S, Pompeo A, Lucon AM, Srougi M, Bhutani MS: EUS for locoregional staging of prostate cancer--a pilot study. Gastrointest Endosc; 2007 Mar;65(3):440-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] EUS for locoregional staging of prostate cancer--a pilot study.
  • BACKGROUND: This was a pilot study on EUS for locoregional evaluation of prostate cancer.
  • OBJECTIVE: Our purpose was to evaluate radial and linear-array EUS in locoregional prostate cancer staging.
  • DESIGN, SETTING, PATIENTS: From April to December 2005, 23 patients were referred to the Department of Urology with a confirmed or highly suspected diagnosis of prostate cancer on the basis of cytohistologic examination of fragments obtained by transrectal US-guided biopsy or transuretheral means.
  • INTERVENTION: An endosonographer and a radiologist with expertise in prostate imaging performed radial and linear EUS examinations without knowledge of the stage of prostate cancer of the referred patients.
  • Histopathologic study of the surgical specimen revealed adenocarcinoma in 20 of 23, atypical adenomatous hyperplasia in 2 of 23, and sclerosing adenosis in 1 of 23.
  • In 3 (3/23) patients EUS did not find a defined lesion, but the surgical specimen showed T1 stage cancer.
  • CONCLUSIONS: EUS presented high sensitivity, specificity, and accuracy for prostate cancer staging.
  • [MeSH-major] Adenocarcinoma / ultrasonography. Endosonography / methods. Prostatic Neoplasms / ultrasonography
  • [MeSH-minor] Aged. Aged, 80 and over. Biopsy. Diagnosis, Differential. Equipment Design. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging / methods. Pilot Projects. Prostatectomy. Rectum. Retrospective Studies. Sensitivity and Specificity. Urethra

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17321246.001).
  • [ISSN] 0016-5107
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Hohenberger W, Bittorf B, Papadopoulos T, Merkel S: Survival after surgical treatment of cancer of the rectum. Langenbecks Arch Surg; 2005 Sep;390(5):363-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Survival after surgical treatment of cancer of the rectum.
  • BACKGROUND AND AIMS: Rectal carcinoma is one of the most prevalent tumour types.
  • PATIENTS/METHODS: The data of 1,067 consecutive patients with solitary invasive rectal carcinoma, resected between 1988 and 1999 at the Department of Surgery of the University of Erlangen, were analysed.
  • Cancer-related survival rate was calculated by univariate and multivariate analysis with respect to all relevant proven and probable prognostic factors.
  • RESULTS: The R classification was found to be the parameter with the greatest influence on survival of patients with rectal carcinoma.
  • The increasing survival rates after treatment of rectal carcinoma have led to a focus on postoperative quality of life.
  • [MeSH-major] Carcinoma / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Quality of Life. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address: